This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)
C3_UNCERTAIN_SECONDARY_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
19574 |
6. Filter based on genotype QC (FinnGen only) |
19574 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
- Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)
- Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)
- Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)
- Secondary uncertain malignant neoplasm
- Secondary and unspecified malignant neoplasm of lymph nodes
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 19574 | 8887 | 10687 |
| Unadjusted period prevalence (%) | 3.95 | 3.03 | 4.71 |
| Median age at first event (years) | 68.60 | 66.64 | 70.23 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4599
- Matched controls
- 45991
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
101.2
323.0
1110
144
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
11713.4
323.0
947
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
323.0
410
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
323.0
321
*
JN4AD
NOMESCO Finland
Body CT examination
17.3
323.0
860
602
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
171.5
323.0
736
51
WF002
NOMESCO Finland
Radical radiotherapy
223.6
323.0
408
20
A03FA01
ATC
metoclopramide; systemic, rectal
17.1
323.0
2358
2662
PJA10
NOMESCO Finland
Exploration of lymph nodes
130.2
323.0
571
50
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
67.3
323.0
583
99
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1032.2
323.0
626
7
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
162.0
323.0
2219
263
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
323.0
374
*
M04AA01
ATC
allopurinol; systemic
5.1
323.0
1495
3998
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
323.0
394
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
1180.2
323.0
524
5
N02AA05
ATC
oxycodone; systemic
6.3
323.0
1367
2890
WW500
NOMESCO Finland
Blood transfusion
17.9
323.0
606
387
A04AA01
ATC
ondansetron; systemic, rectal
36.4
323.0
924
315
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
725.5
323.0
683
11
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
22.6
323.0
496
244
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
323.0
540
*
JN6AD
NOMESCO Finland
CT of torso and neck
84.1
323.0
378
49
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
370.9
323.0
410
12
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
818
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
246.0
323.0
363
16
L03AA13
ATC
pegfilgrastim; parenteral
+∞
323.0
736
*
Z51.5
ICD-10 Finland
Palliative care
21.5
323.0
753
415
L03AA02
ATC
filgrastim; parenteral
671.6
323.0
876
16
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
42.7
323.0
966
284
WF003
NOMESCO Finland
Adjuvant radiotherapy
419.9
323.0
352
9
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
323.0
343
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
323.0
341
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
4571.9
323.0
427
*
A04AA02
ATC
granisetron; systemic, transdermal
1360.6
323.0
882
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.5
323.0
1958
6498
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4756.0
323.0
1129
*
XW000
NOMESCO Finland
Bone marrow biopsy
22.0
323.0
897
500
WF049
NOMESCO Finland
Radiotherapy of metastasis
2556.9
323.0
482
*
JN4BD
NOMESCO Finland
Extensive body CT
25.1
323.0
1685
1035
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
322.7
306
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
1707.9
322.4
310
*
XX3DW
NOMESCO Finland
Time consuming IT work
9.0
309.2
699
894
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
302.4
287
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1413.7
275.6
266
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
88.3
273.3
305
37
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
270.5
257
*
ZX120
NOMESCO Finland
Intravenous
6.1
266.9
807
1559
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
264.1
251
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
255.6
243
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
251.3
239
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
63.5
249.9
292
49
EP1AE
NOMESCO Finland
Neck ultrasound examination
9.1
248.5
556
687
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
82.2
246.8
278
36
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.6
243.4
955
2458
JN4CD
NOMESCO Finland
Very extensive body CT
17.2
242.1
395
250
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
237.5
226
*
116
Kela drug reimbursment
Prostate cancer
+∞
236.5
225
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.6
233.5
653
1127
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
233.3
222
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
152.7
233.1
246
17
115
Kela drug reimbursment
Breast cancer
+∞
231.2
220
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
230.1
219
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
230.1
219
*
WF004
NOMESCO Finland
Palliative radiotherapy
1158.7
227.9
221
*
1XC02
NOMESCO Finland
NA
60.2
226.6
267
47
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2166.1
225.7
217
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
223.7
213
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
222.7
212
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
209.3
951
2778
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
278.2
208.9
212
8
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
34.6
208.4
274
84
L01BC06
ATC
capecitabine; oral
+∞
207.9
198
*
PJA12
NOMESCO Finland
Sentinel node biopsy
426.0
206.0
205
5
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
205.7
196
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
91.0
202.3
225
26
R50.9
ICD-10 Finland
Fever, unspecified
3.8
201.7
979
3021
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
200.4
191
*
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
+∞
200.4
191
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
93.3
200.2
222
25
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
9.4
198.5
431
499
ZX070
NOMESCO Finland
Intensity modified radiotherapy
669.2
196.6
193
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
1862.9
196.1
189
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
196.0
2368
13446
A04AD12
ATC
aprepitant; systemic
2020.2
189.8
183
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
188.8
180
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
188.8
180
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
484.5
188.6
187
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
184.6
176
*
WZC30
NOMESCO Finland
Teaching
4.3
182.8
762
2032
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
181.4
173
*
ZX112
NOMESCO Finland
Subcutaneous
27.2
177.5
248
96
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
176.1
168
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
232.6
174.6
179
8
A04AA55
ATC
palonosetron, combinations; systemic
+∞
174.0
166
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
1820.2
173.9
168
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
1741.7
167.6
162
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
1651.4
160.3
155
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
330.2
160.0
161
5
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.7
154.9
297
269
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
81.3
152.5
172
22
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
150.8
144
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
18.2
150.1
238
137
H02AB06
ATC
prednisolone; systemic
2.3
149.9
2409
15019
J01MA12
ATC
levofloxacin; systemic
2.8
146.1
1131
4770
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
124.9
146.0
157
13
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
145.6
139
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.2
141.3
362
539
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
140.3
134
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
139.0
1308
6160
A02BC02
ATC
pantoprazole; systemic
2.2
138.5
3042
21534
L02AE02
ATC
leuprorelin; implant, parenteral
36.2
137.2
178
51
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
1350.7
135.1
131
*
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
+∞
132.9
127
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
130.8
125
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.0
130.2
270
284
B01AB05
ATC
enoxaparin; parenteral
2.4
128.5
1460
7539
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
+∞
127.7
122
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.8
126.7
384
713
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
125.6
120
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
321.3
122.9
124
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
414.9
122.3
122
*
HA1AA
NOMESCO Finland
X-ray mammography
8.0
121.5
288
380
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
120.3
115
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
119.3
114
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
119.3
114
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
117.1
112
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
115.0
110
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
390.2
115.0
115
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
114.0
109
*
8070/3-C80.9
ICD-O-3
Squamous cell carcinoma, NOS, of unknown primary site
+∞
112.9
108
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
1114.6
112.0
109
*
HAC20
NOMESCO Finland
Total mastectomy
198.2
112.0
116
6
B01AB10
ATC
tinzaparin; parenteral
5.0
111.2
382
817
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.3
110.4
255
322
A79
ICPC
Malignancy NOS
148.6
109.6
116
8
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
11.7
106.7
203
180
L02BB03
ATC
bicalutamide; oral
+∞
106.6
102
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
106.6
102
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
47.7
106.2
130
28
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
105.6
101
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
106.2
104.4
114
11
L02BG04
ATC
letrozole; oral
20.9
103.6
156
77
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.2
102.7
598
2039
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
102.4
98
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.6
102.0
376
865
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
52.1
101.3
122
24
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
96.2
589
2074
L01AA02
ATC
chlorambucil; oral
202.2
95.7
99
5
Y77
ICPC
Malignant neoplasm prostate
482.5
95.7
95
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.1
95.1
397
1029
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
94.1
90
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
15.9
90.9
151
98
L01CB01
ATC
etoposide; systemic
+∞
90.9
87
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
89.9
86
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
445.9
88.4
88
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
29.3
88.1
120
42
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
304.6
88.0
89
*
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
+∞
87.8
84
*
8010/3-C80.9
ICD-O-3
Carcinoma, NOS, of unknown primary site
+∞
87.8
84
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
87.8
84
*
L02BA01
ATC
tamoxifen; oral
107.7
87.2
95
9
H02AB07
ATC
prednisone; oral
2.5
87.1
820
3733
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
85.7
82
*
20199
ICD-8 Finland
Hodgkin's disease
+∞
85.7
82
*
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
+∞
85.7
82
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
85.6
1026
5256
C50.99
ICD-10 Finland
Breast, unspecified
843.3
84.8
83
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.3
83.9
469
1541
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
10.7
83.6
166
160
B72
ICPC
Hodgkin Lymphoma
+∞
83.6
80
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
801.9
80.7
79
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
79.4
76
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
123.6
79.1
85
7
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.3
78.8
220
365
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
108.2
78.1
85
8
J05AB11
ATC
valaciclovir; oral
2.6
76.7
654
2803
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.1
75.8
215
364
212
Kela drug reimbursment
Gout
5.4
74.7
236
456
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
+∞
73.1
70
*
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
+∞
73.1
70
*
Z51.0
ICD-10 Finland
Radiotherapy session
719.1
72.3
71
*
A06AH03
ATC
naloxegol; oral
25.4
72.2
102
41
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
+∞
71.0
68
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
71.0
68
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
357.5
70.8
71
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
68.9
66
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
68.0
435
1561
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
177.6
67.2
70
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.7
66.8
176
270
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
66.8
64
*
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
+∞
66.8
64
*
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
+∞
66.8
64
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
336.8
66.7
67
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
21.7
66.3
98
46
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
142.1
66.1
70
5
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
65.8
63
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
27.0
64.9
90
34
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
64.7
62
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
12.2
64.7
120
101
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
326.5
64.6
65
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
64.2
416
1502
9663/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck
+∞
61.6
59
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
61.6
59
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.6
61.4
163
253
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
8.4
61.1
138
168
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
31.3
60.0
80
26
WW409
NOMESCO Finland
Other aferesis
595.5
59.8
59
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
595.5
59.8
59
*
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
59.5
57
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
59.4
1298
8207
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.5
59.3
125
135
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
15.6
59.0
98
64
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
58.9
1305
8282
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
45.6
58.7
72
16
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
58.4
56
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
202.5
58.1
60
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
574.9
57.8
57
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
57.4
55
*
JAH00
NOMESCO Finland
Laparotomy
5.1
57.2
187
376
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
56.0
400
1535
A07AA02
ATC
nystatin; oral
2.9
55.9
358
1282
TGC00
NOMESCO Finland
Bronchial lavation
4.6
55.8
201
448
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
39.5
55.4
70
18
9695/3-C77.9
ICD-O-3
Follicular lymphoma, grade 1 of lymph node, NOS
+∞
55.3
53
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
55.3
53
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
55.3
53
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
55.3
53
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.5
54.7
275
827
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.3
54.3
149
242
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
54.3
52
*
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
+∞
54.3
52
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
9.1
53.7
116
131
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
533.9
53.6
53
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
58.0
53.6
63
11
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
53.2
51
*
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
53.2
51
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
53.2
51
*
WX402
NOMESCO Finland
General anaesthesia
2.2
53.1
578
2772
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
185.4
53.0
55
*
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
97.9
52.9
58
6
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
52.2
50
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
51.5
788
4360
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.2
51.4
118
148
C80.9
ICD-10 Finland
Malignant neoplasm, primary site unspecified
+∞
51.1
49
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
50.9
750
4084
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.1
50.7
209
531
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.8
50.7
225
611
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
22.4
50.1
73
33
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
50.1
48
*
1AA09
NOMESCO Finland
NA
+∞
50.1
48
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
50.1
48
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
50.1
48
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.5
50.0
105
113
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
49.0
47
*
WW402
NOMESCO Finland
Leucoferesis
+∞
49.0
47
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
25.0
48.9
69
28
A41.9
ICD-10 Finland
Sepsis, unspecified
3.5
48.2
239
711
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
48.0
46
*
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
+∞
48.0
46
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
48.0
46
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
89.4
47.9
53
6
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
10.0
47.1
96
98
KCD02
NOMESCO Finland
Transurethral resection of bladder
14.5
47.0
80
56
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
46.9
45
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
46.9
45
*
ZX108
NOMESCO Finland
Inhalation
14.3
46.1
79
56
R4190
NOMESCO Finland
Nutritional therapy
5.1
46.1
150
300
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
6.0
45.9
131
224
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
45.9
44
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
45.9
44
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
45.9
44
*
4701
FHL
Neck lymph node removal
36.7
45.3
58
16
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
232.1
45.0
46
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
44.9
533
2647
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
44.8
43
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
44.8
43
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
44.8
43
*
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
+∞
44.8
43
*
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
44.8
43
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.1
44.8
184
466
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
44.7
1026
6486
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
44.6
324
1249
X76
ICPC
Malignant neoplasm breast female
227.0
44.0
45
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
29.8
44.0
59
20
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
43.8
42
*
8246/3-C80.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of unknown primary site
+∞
43.8
42
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
18.3
43.1
67
37
R18
ICD-10 Finland
Ascites
6.5
42.8
115
182
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
42.8
41
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
42.8
41
*
N02BE01
ATC
paracetamol; systemic, rectal
1.6
42.4
3616
31779
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
61.8
42.2
49
8
C50
ICD-10 Finland
Malignant neoplasm of breast
421.3
42.2
42
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
20.6
42.2
63
31
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
32.7
41.9
55
17
JAH01
NOMESCO Finland
Laparoscopy
3.7
41.9
191
531
M05BX04
ATC
denosumab; parenteral
3.4
41.8
216
663
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
41.7
40
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
41.7
40
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
41.7
40
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
41.7
40
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
41.7
40
*
GD1AD
NOMESCO Finland
Thorax CT examination
3.4
41.6
213
650
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.9
41.5
269
967
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
6.1
41.0
115
193
C90.0
ICD-10 Finland
Multiple myeloma
211.8
40.9
42
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
40.8
1759
13107
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
111.0
40.8
44
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
40.7
39
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
40.7
39
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
40.7
39
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
40.7
39
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
40.7
39
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
40.5
498
2505
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
40.1
1917
14617
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
5.4
40.0
123
231
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
39.9
1268
8744
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
206.7
39.9
41
*
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
+∞
39.6
38
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
39.6
38
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
39.6
38
*
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
+∞
39.6
38
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
39.6
38
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
39.6
38
*
ZZR00
NOMESCO Finland
Flap of skin
9.9
39.3
80
82
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
390.6
39.1
39
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
14.1
39.1
67
48
L01CA04
ATC
vinorelbine; systemic
+∞
38.6
37
*
L02BB04
ATC
enzalutamide; oral
+∞
38.6
37
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.0
38.4
158
402
TPX15
NOMESCO Finland
Removal of vascular injection port
23.2
38.3
55
24
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.7
38.1
173
479
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
196.5
37.8
39
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.2
37.8
214
701
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
134.4
37.7
40
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
37.5
36
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
37.5
36
*
L01BB05
ATC
fludarabine; systemic
+∞
37.5
36
*
L02BG06
ATC
exemestane; oral
+∞
37.5
36
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
37.5
36
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.7
37.0
271
1049
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
9.2
36.9
78
86
J94.8
ICD-10 Finland
Other specified pleural conditions
5.3
36.6
114
218
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
36.5
35
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
36.5
35
*
9652/3-C77.9
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS
+∞
36.5
35
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
36.2
324
1401
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
186.4
35.8
37
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
35.4
34
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
35.4
34
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
35.4
34
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
35.4
34
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
35.4
34
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.1
35.4
99
166
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
6.2
35.3
97
159
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
8.1
35.1
80
100
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
34.4
33
*
9659/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph node, NOS
+∞
34.4
33
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
34.4
33
*
8720/3-C80.9
ICD-O-3
Malignant melanoma, NOS, of unknown primary site
+∞
34.4
33
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
34.4
33
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
34.4
33
*
9659/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of multiple regions
+∞
34.4
33
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
57.6
34.2
40
7
UJF32
NOMESCO Finland
Coloscopy
1.6
34.0
1018
6861
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
339.5
33.9
34
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.5
33.7
122
275
WX110
NOMESCO Finland
Local anesthesy
1.5
33.5
2548
21131
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
33.4
32
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
33.4
32
*
L02BX02
ATC
degarelix; parenteral
+∞
33.4
32
*
C81
ICD-10 Finland
Hodgkin lymphoma
+∞
33.4
32
*
JAH21
NOMESCO Finland
Staging laparoscopy
+∞
33.4
32
*
KA1FN
NOMESCO Finland
Isotope renography
14.5
33.2
56
39
C03CA01
ATC
furosemide; systemic
1.5
33.1
1496
11124
L02AE03
ATC
goserelin; implant
15.0
33.0
55
37
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
329.3
32.9
33
*
A06AD11
ATC
lactulose; oral
1.7
32.8
703
4305
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
24.4
32.7
46
19
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
32.3
31
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
32.3
31
*
L01AX03
ATC
temozolomide; systemic
+∞
32.3
31
*
V03AF03
ATC
calcium folinate; systemic
+∞
32.3
31
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
32.3
31
*
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
+∞
32.3
31
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
32.3
31
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
32.3
31
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
32.3
31
*
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
13.5
32.2
56
42
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.0
31.8
457
2437
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
88.2
31.7
35
*
A04AA03
ATC
tropisetron; systemic
114.1
31.7
34
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
27.1
31.4
43
16
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
+∞
31.3
30
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
31.3
30
*
9591/3-C77.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes
+∞
31.3
30
*
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
+∞
31.3
30
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
31.3
30
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
11.3
31.2
59
53
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
10.5
31.1
61
59
TGD00
NOMESCO Finland
Needle biopsy of lung
17.9
30.9
48
27
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.3
30.7
116
273
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
161.0
30.7
32
*
D77
ICPC
Malignant digestive neopl other/NOS
161.0
30.7
32
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
8.2
30.7
69
85
JN4DD
NOMESCO Finland
Scout CT scan of torso
46.6
30.6
37
8
J01MA14
ATC
moxifloxacin; systemic
2.1
30.5
380
1915
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.4
30.4
273
1183
WF099
NOMESCO Finland
Other radiotherapy
22.2
30.4
44
20
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
30.2
29
*
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
30.2
29
*
C82.0
ICD-10 Finland
Follicular lymphoma grade I
+∞
30.2
29
*
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
+∞
30.2
29
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
30.2
29
*
390
Kela drug reimbursment
Ibrutinib
+∞
30.2
29
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
30.2
29
*
J05AB01
ATC
aciclovir; systemic
1.7
29.8
787
5107
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
29.2
28
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
29.2
28
*
3AA13
NOMESCO Finland
NA
+∞
29.2
28
*
L02BA03
ATC
fulvestrant; parenteral
+∞
29.2
28
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
29.2
28
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
80.6
28.7
32
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
10.9
28.7
55
51
N02AA01
ATC
morphine; systemic, rectal
6.8
28.6
73
109
TQW99
NOMESCO Finland
Other minor procedure on skin
3.0
28.6
175
605
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
12.6
28.5
51
41
9650/3-C77.1
ICD-O-3
Hodgkin lymphoma, NOS, of intrathoracic lymph nodes
+∞
28.1
27
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
28.1
27
*
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
+∞
28.1
27
*
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
+∞
28.1
27
*
2019X
ICD-9 Finland
Hodgkin's disease, unspecified
+∞
28.1
27
*
9670/3-C77.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS
+∞
28.1
27
*
C80.98
ICD-10 Finland
Malignant tumor without specified localization other specified histology
+∞
28.1
27
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
28.1
27
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
31.1
28.1
37
12
JMA10
NOMESCO Finland
Transabdominal total splenectomy
14.4
27.8
47
33
J01DB01
ATC
cefalexin; oral
1.4
27.8
3257
28810
C82
ICD-10 Finland
Follicular lymphoma
283.1
27.8
28
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
283.1
27.8
28
*
B01AB04
ATC
dalteparin; parenteral
2.6
27.7
215
860
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
145.8
27.6
29
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.9
27.5
117
308
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
13.9
27.5
47
34
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
16.4
27.5
44
27
Z31.6
ICD-10 Finland
General counselling and advice on procreation
11.2
27.5
52
47
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
5.4
27.4
84
159
E83.50
ICD-10 Finland
Hypercalcemia
5.5
27.4
82
151
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
13.1
27.3
48
37
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
11.4
27.3
51
45
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.7
27.3
192
728
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
27.1
26
*
9650/3-C77.9
ICD-O-3
Hodgkin lymphoma, NOS, of lymph node, NOS
+∞
27.1
26
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
27.1
26
*
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
27.1
26
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
27.1
26
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
27.1
26
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
27.1
26
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
27.1
26
*
192
Kela drug reimbursment
Fulvestrant
+∞
27.1
26
*
WW200
NOMESCO Finland
Immunization
3.4
27.1
135
405
L02BG03
ATC
anastrozole; oral
38.0
27.1
34
9
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
62.4
26.9
31
5
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.6
26.9
210
843
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.8
26.8
91
193
JAH20
NOMESCO Finland
Staging laparotomy
272.5
26.7
27
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
97.3
26.7
29
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
140.8
26.6
28
*
B02
ICPC
Lymph gland(s) enlarged/painful
8.9
26.6
57
65
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
26.3
383
2049
H01CB02
ATC
octreotide; parenteral
52.0
26.2
31
6
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
25.9
26.1
36
14
GEA00
NOMESCO Finland
Mediastinoscopy
14.3
26.1
44
31
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.1
26.1
72
120
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
26.1
25
*
C83.71
ICD-10 Finland
Burkitt's tumour
+∞
26.1
25
*
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
+∞
26.1
25
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
26.1
25
*
L02BX03
ATC
abiraterone; oral
+∞
26.1
25
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
26.1
25
*
C80.91
ICD-10 Finland
Malignant tumor without specified localization epidermoid carcinoma
+∞
26.1
25
*
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
26.1
25
*
9680/3-C77.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes
+∞
26.1
25
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.4
26.0
226
960
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.7
25.8
89
192
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
73.0
25.8
29
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
261.9
25.7
26
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
261.9
25.7
26
*
D69.5
ICD-10 Finland
Secondary thrombocytopenia
17.5
25.7
40
23
JFB30
NOMESCO Finland
Right hemicolectomy
8.2
25.5
57
70
D75
ICPC
Malignant neoplasm colon/rectum
44.5
25.5
31
7
1512
Kela drug reimbursment
Ibrutinib
+∞
25.0
24
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
25.0
24
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
25.0
24
*
9652/3-C77.8
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of multiple regions
+∞
25.0
24
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
25.0
24
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
25.0
24
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
10.8
25.0
48
45
H02AB09
ATC
hydrocortisone; systemic
3.6
24.8
113
316
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
251.4
24.7
25
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
251.4
24.7
25
*
JFB00
NOMESCO Finland
Partial resection of small intestine
4.9
24.4
81
168
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
18.6
24.3
37
20
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
24.3
1460
11329
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
6.9
24.2
61
90
N05CF01
ATC
zopiclone; oral
1.4
24.2
1328
10120
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
5.0
24.2
79
161
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
24.0
23
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
24.0
23
*
9823/3-C77.8
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions
+∞
24.0
23
*
8480/3-C80.9
ICD-O-3
Mucinous adenocarcinoma of unknown primary site
+∞
24.0
23
*
9652/3-C77.0
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of head, face and neck
+∞
24.0
23
*
UKC02
NOMESCO Finland
Cystoscopy
1.6
23.9
652
4247
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
22.8
23.8
34
15
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
23.7
246
1144
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
87.2
23.7
26
*
5702
FHL
Local lymph node removal (eg armpit, groin)
41.6
23.6
29
7
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
8.3
23.5
52
63
L57.0
ICD-10 Finland
Actinic keratosis
2.0
23.3
321
1677
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.9
23.2
142
494
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
7.6
23.0
54
72
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
22.9
22
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
22.9
22
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
22.9
22
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
22.9
22
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
22.9
22
*
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
22.9
22
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
22.8
791
5464
UJC01
NOMESCO Finland
Scopy of lower throat
6.6
22.7
59
91
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
83.8
22.7
25
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.7
22.6
155
580
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
23.0
22.5
32
14
J02AC03
ATC
voriconazole; systemic
23.0
22.5
32
14
S77
ICPC
Malignant neoplasm of skin
19.5
22.1
33
17
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
22.1
369
2070
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
52.2
22.1
26
5
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
8.8
22.0
47
54
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.6
21.9
159
614
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
21.9
21
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
21.9
21
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
21.9
21
*
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
+∞
21.9
21
*
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
21.9
21
*
1501
Kela drug reimbursment
Palbociclib
+∞
21.9
21
*
8240/3-C80.9
ICD-O-3
Neuroendocrine tumor, NOS, of unknown primary site
+∞
21.9
21
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
21.9
21
*
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
+∞
21.9
21
*
TAB00
NOMESCO Finland
Lumbar puncture
2.5
21.8
172
696
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
21.8
1237
9452
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
17.1
21.7
34
20
WX002
NOMESCO Finland
Sedation and analgesia
1.5
21.6
750
5169
E34.0
ICD-10 Finland
Carcinoid syndrome
115.5
21.6
23
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.8
21.5
92
245
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
23.2
21.2
30
13
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
11.2
20.9
39
35
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
20.8
20
*
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
+∞
20.8
20
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
20.8
20
*
9663/3-C77.1
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of intrathoracic lymph nodes
+∞
20.8
20
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
20.8
20
*
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
20.8
20
*
2016A
ICD-9 Finland
Hodgkin's disease, Mixed cellularity
+∞
20.8
20
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
20.8
20
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
20.8
20
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
20.8
20
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
20.8
20
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
20.8
20
*
9690/3-C77.4
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
20.8
20
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
210.8
20.6
21
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
110.5
20.6
22
*
SPAT1153
SPAT
Removal of sutures
1.4
20.3
1152
8781
ZXA00
NOMESCO Finland
Right side
1.4
20.2
1067
8021
A02BC01
ATC
omeprazole; systemic
1.4
20.2
1124
8535
TKE00
NOMESCO Finland
Needle biopsy of prostate
2.8
20.2
134
493
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
48.2
20.1
24
5
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.7
20.1
88
240
R06AE07
ATC
cetirizine; oral
1.4
20.1
1485
11852
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
19.8
19
*
9680/3-C77.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
19.8
19
*
9691/3-C77.0
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of head, face and neck
+∞
19.8
19
*
8249/3-C80.9
ICD-O-3
Neuroendocrine tumor, grade 2 of unknown primary site
+∞
19.8
19
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
19.8
19
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
19.8
19
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
19.8
19
*
8041/3-C80.9
ICD-O-3
Small cell carcinoma, NOS, of unknown primary site
+∞
19.8
19
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
19.8
19
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
19.8
19
*
2014A
ICD-9 Finland
Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,""""LYMPHOCYTIC PREDOMINANCE"""",""""NODULAR""""]
+∞
19.8
19
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
19.8
19
*
6103
FHL
Staging laparotomy (to study the reticuloendothelial system)
+∞
19.8
19
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
4.3
19.8
74
175
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
73.8
19.7
22
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
16.4
19.6
31
19
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
16.4
19.6
31
19
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
19.4
19.5
29
15
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.6
19.2
89
254
KAC10
NOMESCO Finland
Total nephrectomy with capsule
26.1
19.1
26
10
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.1
18.9
108
358
R84
ICPC
Malignant neoplasm bronchus/lung
55.2
18.9
22
*
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
55.2
18.9
22
*
R4110
NOMESCO Finland
Physiotherapy
1.4
18.9
923
6824
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
18.8
197
918
127
Kela drug reimbursment
Transplant complication
4.5
18.8
66
147
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.8
18.8
125
461
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
18.8
18
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
18.8
18
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
18.8
18
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
18.8
18
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
18.8
18
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
18.8
18
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
18.8
18
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
18.8
18
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
18.8
18
*
197
Kela drug reimbursment
Sunitinib
+∞
18.8
18
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
18.8
18
*
9659/3-C77.3
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of axilla or arm
+∞
18.8
18
*
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
+∞
18.8
18
*
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
18.8
18
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
18.8
18
*
394
Kela drug reimbursment
Palbociclib
+∞
18.8
18
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
18.8
18
*
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
11.8
18.7
34
29
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
4.3
18.7
70
166
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.9
18.6
118
420
J01MA02
ATC
ciprofloxacin; systemic
1.4
18.6
1516
12255
A98
ICPC
Health maint/preventive medicine
0.7
18.6
3409
36721
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
100.4
18.6
20
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
9.3
18.6
38
41
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
6.7
18.5
47
71
R11
ICD-10 Finland
Nausea and vomiting
1.9
18.4
290
1593
K83.1
ICD-10 Finland
Obstruction of bile duct
5.0
18.3
58
116
1CX01
NOMESCO Finland
NA
25.1
18.2
25
10
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
19.4
18.1
27
14
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.3
18.1
92
283
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
5.9
18.1
50
85
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
4.5
18.1
64
144
Z51.88
ICD-10 Finland
Other specified medical care
3.3
18.0
92
284
JAL30
NOMESCO Finland
Omentectomy
11.4
17.9
33
29
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
18.1
17.7
27
15
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
17.7
17
*
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
+∞
17.7
17
*
L01EL01
ATC
ibrutinib; oral
+∞
17.7
17
*
UJC20
NOMESCO Finland
Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck
+∞
17.7
17
*
L01XE33
ATC
[U] palbociclib; oral
+∞
17.7
17
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
17.7
17
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
17.7
17
*
2015A
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, CELLULAR PHASE]
+∞
17.7
17
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.9
17.6
73
191
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
3.7
17.6
77
211
H01CB03
ATC
lanreotide; parenteral
95.4
17.6
19
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
180.6
17.5
18
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
28.9
17.4
23
8
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.0
17.3
101
343
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
17.0
349
2088
JDE00
NOMESCO Finland
Gastrojejunostomy
31.6
17.0
22
7
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
5.6
17.0
49
88
XX1AD
NOMESCO Finland
Other CT-examination
50.2
17.0
20
*
ZXC96
NOMESCO Finland
Robot assisted procedure
6.4
17.0
44
69
GDC00
NOMESCO Finland
Lobectomy of lung
25.7
16.9
23
9
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
12.1
16.8
30
25
B02.9
ICD-10 Finland
Zoster without complication
2.0
16.8
233
1223
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
63.5
16.7
19
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
16.7
16
*
C76.1
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Thorax
+∞
16.7
16
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
16.7
16
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
16.7
16
*
9651/3-C77.9
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph node, NOS
+∞
16.7
16
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
16.7
16
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
16.7
16
*
198
Kela drug reimbursment
Sorafenib
+∞
16.7
16
*
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
16.7
16
*
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
+∞
16.7
16
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
+∞
16.7
16
*
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
90.4
16.6
18
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
90.4
16.6
18
*
ZX121
NOMESCO Finland
Central venous catheter
16.3
16.5
26
16
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
170.5
16.5
17
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
170.5
16.5
17
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
27.6
16.5
22
8
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.3
16.4
50
96
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.9
16.4
67
173
HAB99
NOMESCO Finland
Other partial excision of mammary gland
5.8
16.4
46
80
S18
ICPC
Laceration/cut
1.3
16.4
1494
12226
EMB10
NOMESCO Finland
Tonsillectomy
2.3
16.4
153
680
N03AX16
ATC
pregabalin; oral
1.4
16.3
836
6220
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
16.2
149
658
9101
FHL
Bone biopsy
15.4
16.1
26
17
TQW20
NOMESCO Finland
Tatoe
30.1
16.1
21
7
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.0
16.0
201
1016
ZXA05
NOMESCO Finland
Left side
1.4
16.0
987
7589
JFF10
NOMESCO Finland
Loop enterostomy
11.2
15.7
29
26
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
15.6
15
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
15.6
15
*
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
15.6
15
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
15.6
15
*
176
Kela drug reimbursment
Regorafenib
+∞
15.6
15
*
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
+∞
15.6
15
*
372
Kela drug reimbursment
Idelalisib
+∞
15.6
15
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
15.6
15
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
15.6
15
*
8020/3-C80.9
ICD-O-3
Carcinoma, undifferentiated, NOS, of unknown primary site
+∞
15.6
15
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
15.6
15
*
1CD02
NOMESCO Finland
NA
+∞
15.6
15
*
9680/3-C77.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm
+∞
15.6
15
*
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
15.6
15
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
15.6
15
*
369
Kela drug reimbursment
Regorafenib
+∞
15.6
15
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
+∞
15.6
15
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
15.6
15
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.2
15.6
153
696
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
85.3
15.6
17
*
B73
ICPC
Leukaemia
85.3
15.6
17
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
11.7
15.5
28
24
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.3
15.5
57
134
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
160.4
15.5
16
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
160.4
15.5
16
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
10.1
15.4
30
30
KA3EB
NOMESCO Finland
Antegrade pyelography
9.4
15.4
31
33
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
12.3
15.3
27
22
A41.8
ICD-10 Finland
Other specified sepsis
3.2
15.2
80
254
A09AA02
ATC
multienzymes (lipase, protease etc.)
3.3
15.2
75
227
SPAT1109
SPAT
Analgesia with portable analgesic pump
8.3
15.2
33
40
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
11.8
15.0
27
23
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.5
15.0
70
203
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
14.8
685
4986
EMA10
NOMESCO Finland
Biopsy of tonsil
15.1
14.8
24
16
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
12.4
14.8
26
21
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.5
14.7
114
459
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
25.1
14.7
20
8
120
Kela drug reimbursment
Hypogammaglobulinaemia
18.4
14.7
22
12
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
18.4
14.7
22
12
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
14.6
14
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
14.6
14
*
PJ2CT
NOMESCO Finland
Biopsy of lymphnode with CT guidance
+∞
14.6
14
*
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
14.6
14
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
14.6
14
*
189
Kela drug reimbursment
Imatinib
+∞
14.6
14
*
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
+∞
14.6
14
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
14.6
14
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
14.6
14
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
14.6
14
*
180
Kela drug reimbursment
Interferon alfa
+∞
14.6
14
*
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
+∞
14.6
14
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
14.6
14
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
14.6
14
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
14.6
14
*
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
+∞
14.6
14
*
C85.0
ICD-10 Finland
Lymphosarcoma
+∞
14.6
14
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
14.6
14
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
14.6
14
*
L01XE04
ATC
[U] sunitinib; oral
+∞
14.6
14
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
150.4
14.5
15
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
150.4
14.5
15
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
10.9
14.5
27
25
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
8.4
14.4
31
37
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
36.1
14.4
18
5
L02AE04
ATC
triptorelin; parenteral
36.1
14.4
18
5
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.1
14.4
161
775
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
9.4
14.4
29
31
WW200
SPAT
NA
0.5
14.3
119
2296
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
14.3
896
6885
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
27.2
14.3
19
7
SPAT1255
SPAT
Intravenous administration of medicine
1.8
14.3
244
1383
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
19.2
14.2
21
11
TJA10
NOMESCO Finland
Laparocentesis
22.3
14.2
20
9
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
22.3
14.2
20
9
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
22.3
14.2
20
9
TJF80
NOMESCO Finland
Ostomy education
9.7
14.2
28
29
L01AA01
ATC
cyclophosphamide; systemic
7.7
14.1
32
42
ENA10
NOMESCO Finland
Biopsy of pharynx
10.9
14.0
26
24
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
7.2
14.0
33
46
N06DX01
ATC
memantine; oral
0.5
13.9
108
2127
TQB05
NOMESCO Finland
Puncture of skin of trunk
9.4
13.9
28
30
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
12.7
13.9
24
19
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
53.5
13.8
16
*
UJK02
NOMESCO Finland
ERCP
2.6
13.6
101
400
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
13.5
13
*
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
13.5
13
*
9651/3-C77.0
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of head, face and neck
+∞
13.5
13
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
+∞
13.5
13
*
C16.00
ICD-10 Finland
Cardia
+∞
13.5
13
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
13.5
13
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
13.5
13
*
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
+∞
13.5
13
*
L01BC53
ATC
tegafur, combinations; systemic
+∞
13.5
13
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
13.5
13
*
8140/3-C26.9
ICD-O-3
Adenocarcinoma, NOS, of gastrointestinal tract, NOS
+∞
13.5
13
*
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
13.5
13
*
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
+∞
13.5
13
*
159
Kela drug reimbursment
Pazopanib
+∞
13.5
13
*
9659/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of head, face and neck
+∞
13.5
13
*
L01XE01
ATC
[U] imatinib; oral
+∞
13.5
13
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
13.5
13
*
C07.70
ICD-10 Finland
Malignant tumor of the superficial part of the parotid gland
+∞
13.5
13
*
C83.70
ICD-10 Finland
Non-Hodgkin's lymphoma of the Burkitt type
+∞
13.5
13
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
13.5
13
*
L01XE21
ATC
[U] regorafenib; oral
+∞
13.5
13
*
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
4.9
13.5
43
88
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.9
13.5
81
283
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
140.3
13.4
14
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
140.3
13.4
14
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.8
13.4
56
149
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
4.4
13.4
48
111
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
25.8
13.3
18
7
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
18.2
13.3
20
11
4704
FHL
Neck tumor removal
21.2
13.3
19
9
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
5.4
13.2
39
73
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
13.8
13.2
22
16
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
40.2
13.1
16
*
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
13.1
204
1119
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.6
13.1
94
365
A05AA02
ATC
ursodeoxycholic acid; oral
3.6
13.0
58
164
B03XA02
ATC
darbepoetin alfa; parenteral
2.9
12.9
75
257
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
50.1
12.8
15
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.7
12.8
88
334
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.1
12.7
48
117
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
10.5
12.7
24
23
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
5.1
12.7
39
77
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.5
12.6
97
1913
EP3AT
NOMESCO Finland
Neck soft tissue biopsy with ultrasound guidance
70.0
12.6
14
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
70.0
12.6
14
*
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
70.0
12.6
14
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
70.0
12.6
14
*
DAB10
NOMESCO Finland
Partial excision of auricle
70.0
12.6
14
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.3
12.6
46
109
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
8.2
12.5
27
33
20013
ICD-8 Finland
Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)
+∞
12.5
12
*
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
+∞
12.5
12
*
8130/3-C67.9
ICD-O-3
Papillary urothelial carcinoma of bladder, NOS
+∞
12.5
12
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
12.5
12
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
12.5
12
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
12.5
12
*
8000/3-C76.2
ICD-O-3
Neoplasm, malignant of abdomen, NOS
+∞
12.5
12
*
9670/3-C80.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of unknown primary site
+∞
12.5
12
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
12.5
12
*
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
+∞
12.5
12
*
L01XE23
ATC
[U] dabrafenib; oral
+∞
12.5
12
*
C76.7
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Other ill-defined sites
+∞
12.5
12
*
C76.0
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Head, face and neck
+∞
12.5
12
*
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
+∞
12.5
12
*
L01BC59
ATC
trifluridine, combinations; systemic
+∞
12.5
12
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
12.5
12
*
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
+∞
12.5
12
*
C83.40
ICD-10 Finland
Immunoblast large cell lymphoma
+∞
12.5
12
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
12.5
12
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
12.5
12
*
L01XX47
ATC
[U] idelalisib; oral
+∞
12.5
12
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
12.5
12
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
12.5
12
*
9650/3-C77.8
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of multiple regions
+∞
12.5
12
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
12.5
12
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
130.3
12.4
13
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
130.3
12.4
13
*
UDQ22
NOMESCO Finland
Microlaryngoscopy
4.7
12.4
41
88
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
12.3
212
1207
DHB00
NOMESCO Finland
Excision of lesion of external nose
8.4
12.2
26
31
X77
ICPC
Malignant neopl genital female other
37.6
12.2
15
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
12.2
133
635
ZX050
NOMESCO Finland
Stereotactic radiotherapy
12.4
12.1
21
17
SPAT1088
SPAT
Blood transfusion
6.9
12.1
29
42
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
26.7
12.0
16
6
ZX114
NOMESCO Finland
Intramuscular
3.3
12.0
58
175
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
12.0
653
4887
EBA10
NOMESCO Finland
Surgical removal of tooth
1.6
11.9
327
2122
JFF23
NOMESCO Finland
Transversostomy
7.5
11.9
27
36
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.8
11.9
74
265
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
11.8
163
857
B74
ICPC
Malignant neoplasm blood other
16.4
11.6
18
11
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
30.1
11.6
15
5
6BA02
NOMESCO Finland
NA
12.5
11.6
20
16
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
11.1
11.5
21
19
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.9
11.5
46
119
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
11.5
11
*
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
+∞
11.5
11
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
11.5
11
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
11.5
11
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
11.5
11
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
11.5
11
*
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
+∞
11.5
11
*
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
11.5
11
*
9695/3-C77.0
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of head, face and neck
+∞
11.5
11
*
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
+∞
11.5
11
*
PJ002
NOMESCO Finland
Radical radiotherapy of neck, clavicle and axilla
+∞
11.5
11
*
8140/3-C76.2
ICD-O-3
Adenocarcinoma, NOS, of abdomen, NOS
+∞
11.5
11
*
C83.5
ICD-10 Finland
Lymphoblastic (diffuse) lymphoma
+∞
11.5
11
*
9690/3-C77.2
ICD-O-3
Follicular lymphoma, NOS, of intra-abdominal lymph nodes
+∞
11.5
11
*
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
+∞
11.5
11
*
9590/3-C77.9
ICD-O-3
Malignant lymphoma, NOS, of lymph node, NOS
+∞
11.5
11
*
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
+∞
11.5
11
*
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
+∞
11.5
11
*
9698/3-C77.0
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of head, face and neck
+∞
11.5
11
*
9695/3-C77.4
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of inguinal region or leg
+∞
11.5
11
*
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
+∞
11.5
11
*
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
+∞
11.5
11
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
11.5
11
*
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
+∞
11.5
11
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
11.5
11
*
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
+∞
11.5
11
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
11.5
11
*
L01XE25
ATC
[U] trametinib; oral
+∞
11.5
11
*
L03AB05
ATC
interferon alfa-2b; parenteral
13.6
11.4
19
14
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
120.2
11.4
12
*
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
35.1
11.3
14
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
35.1
11.3
14
*
R50.8
ICD-10 Finland
Other specified fever
6.5
11.2
28
43
ELB50
NOMESCO Finland
Total parotidectomy
17.0
11.2
17
10
XKD00
NOMESCO Finland
Uroflowmetry
1.4
11.1
570
4218
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
25.1
11.1
15
6
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
4.3
11.1
40
94
C10AA07
ATC
rosuvastatin; oral
0.7
11.1
562
7335
P20
ICPC
Memory disturbance
0.7
11.0
266
3943
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
43.4
10.9
13
*
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
43.4
10.9
13
*
6753
FHL
Transabdominal splenectomy
15.5
10.8
17
11
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.9
10.8
65
230
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
10.8
1196
9934
A21
ICPC
Risk factor for malignancy
28.1
10.7
14
5
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
17.8
10.7
16
9
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
17.8
10.7
16
9
C10AA05
ATC
atorvastatin; oral
0.8
10.7
1170
13846
J02AC01
ATC
fluconazole; systemic
1.3
10.7
1155
9558
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.7
10.7
71
264
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
5.6
10.7
30
54
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
7.5
10.6
24
32
PJD99
NOMESCO Finland
Excision of other lymph nodes
60.1
10.6
12
*
OAA41
NOMESCO Finland
Health check based on individual needs
60.1
10.6
12
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
10.5
165
910
G03HA01
ATC
cyproterone; systemic
11.2
10.5
19
17
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
110.2
10.4
11
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
110.2
10.4
11
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
110.2
10.4
11
*
C84.0
ICD-10 Finland
Mycosis fungoides
110.2
10.4
11
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
110.2
10.4
11
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
10.4
10
*
9691/3-C77.4
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of inguinal region or leg
+∞
10.4
10
*
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
+∞
10.4
10
*
L01XE11
ATC
[U] pazopanib; oral
+∞
10.4
10
*
9670/3-C77.8
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions
+∞
10.4
10
*
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
10.4
10
*
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
+∞
10.4
10
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
D48.49
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum, of unknown origin
+∞
10.4
10
*
C83.41
ICD-10 Finland
Immunoblastic (diffuse)
+∞
10.4
10
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
10.4
10
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
10.4
10
*
8010/3-C34.9
ICD-O-3
Carcinoma, NOS, of lung, NOS
+∞
10.4
10
*
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
+∞
10.4
10
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
10.4
10
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
+∞
10.4
10
*
9591/3-C80.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site
+∞
10.4
10
*
L01XE05
ATC
[U] sorafenib; oral
+∞
10.4
10
*
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
+∞
10.4
10
*
H03AA01
ATC
levothyroxine sodium; systemic
1.3
10.4
762
5974
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
4.7
10.4
34
73
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
10.4
716
5565
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.6
10.3
167
2696
D76
ICPC
Malignant neoplasm pancreas
32.6
10.3
13
*
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
4.9
10.3
32
65
JG1BG
NOMESCO Finland
MRI of rectum
18.8
10.2
15
8
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.7
10.2
68
254
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
4.3
10.1
36
84
N06DA03
ATC
rivastigmine; oral, transdermal
0.4
10.0
50
1138
JLC30
NOMESCO Finland
Pancreatoduodenectomy
11.3
10.0
18
16
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.5
10.0
83
1595
L03AA04
ATC
NA
14.6
10.0
16
11
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
14.6
10.0
16
11
WX892
NOMESCO Finland
Monitored bed care
1.6
10.0
271
1753
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
7.2
10.0
23
32
M05BA02
ATC
clodronic acid; systemic
40.1
10.0
12
*
KEB00
NOMESCO Finland
Biopsy of prostate
4.2
9.9
36
86
N05AX08
ATC
risperidone; systemic
0.6
9.9
143
2371
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.3
9.8
84
362
R06.0
ICD-10 Finland
Dyspnoea
1.3
9.8
917
7437
104
Kela drug reimbursment
Thyroid insufficiency
1.6
9.8
233
1461
ZXC40
NOMESCO Finland
Use of ultrasound
5.6
9.8
27
48
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
7.0
9.8
23
33
UDQ02
NOMESCO Finland
Direct laryngoscopy
4.5
9.7
33
74
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
4.9
9.7
30
61
WX704
NOMESCO Finland
Intubation
1.7
9.7
207
1257
J94.9
ICD-10 Finland
Pleural condition, unspecified
4.6
9.7
32
70
C91.7
ICD-10 Finland
Other lymphoid leukaemia
55.1
9.6
11
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
55.1
9.6
11
*
NF3AA
NOMESCO Finland
Femur X-ray examination
2.5
9.6
73
297
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.6
9.5
68
265
GD6AD
NOMESCO Finland
CT of chest and neck
15.0
9.5
15
10
G04BE03
ATC
sildenafil; oral
5.2
9.5
28
54
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
100.2
9.4
10
*
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
30.1
9.4
12
*
GAA31
NOMESCO Finland
Thoracoscopy
7.5
9.4
21
28
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.5
9.4
69
276
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
9.4
9
*
9670/3-C77.3
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm
+∞
9.4
9
*
1XC03
NOMESCO Finland
NA
+∞
9.4
9
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
9.4
9
*
1XC12
NOMESCO Finland
NA
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
9.4
9
*
C78.5
ICD-10 Finland
Secondary malignant neoplasm of large intestine and rectum
+∞
9.4
9
*
191
Kela drug reimbursment
Erlotinib
+∞
9.4
9
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
9.4
9
*
ZX131
NOMESCO Finland
Intrathecal
+∞
9.4
9
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
9.4
9
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
9.4
9
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
9.4
9
*
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
9.4
9
*
158
Kela drug reimbursment
Everolimus
+∞
9.4
9
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
9.4
9
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
9.4
9
*
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
+∞
9.4
9
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
9.4
9
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
9.4
9
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
9.4
9
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
3.8
9.4
38
101
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.7
9.4
39
106
J93.8
ICD-10 Finland
Other pneumothorax
6.2
9.4
24
39
KAD00
NOMESCO Finland
Partial nephrectomy
12.3
9.3
16
13
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
21.7
9.3
13
6
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
21.7
9.3
13
6
A07AA09
ATC
vancomycin; oral
2.9
9.3
54
186
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
9.3
250
1618
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
2.9
9.2
54
188
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
6.4
9.2
23
36
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
13.7
9.2
15
11
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
13.7
9.2
15
11
A02BA02
ATC
ranitidine; systemic
1.3
9.1
751
5985
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
11.5
9.0
16
14
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
15.6
9.0
14
9
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
15.6
9.0
14
9
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
36.7
9.0
11
*
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
36.7
9.0
11
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.6
9.0
63
246
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
9.0
542
4120
P01AB01
ATC
metronidazole; oral, rectal
1.2
8.9
1255
10676
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
18.6
8.9
13
7
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
24.0
8.9
12
5
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
4.0
8.9
34
86
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.8
8.8
54
195
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
6.8
8.8
21
31
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
8.8
232
1492
QBA10
NOMESCO Finland
Incision of skin of trunk
3.8
8.8
35
92
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
4.3
8.8
31
73
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.3
8.8
79
350
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
9.5
8.8
17
18
JJA20
NOMESCO Finland
Open biopsy of liver
9.5
8.8
17
18
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
4.6
8.7
29
64
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
5.1
8.7
26
51
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
5.3
8.7
25
47
ZZR10
NOMESCO Finland
Flap of skin and muscle
7.2
8.7
20
28
WX400
NOMESCO Finland
Inhalation anesthesy
1.9
8.7
114
592
RS220
NOMESCO Finland
NA
3.1
8.7
46
151
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
3.3
8.7
41
124
1XC07
NOMESCO Finland
NA
50.1
8.7
10
*
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
50.1
8.7
10
*
WE100
NOMESCO Finland
Profylactic cytostatic therapy
50.1
8.7
10
*
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
50.1
8.7
10
*
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
50.1
8.7
10
*
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
50.1
8.7
10
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.9
8.6
114
596
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
7.6
8.6
19
25
WX882
NOMESCO Finland
High dependency care
2.1
8.6
89
421
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
3.8
8.6
34
89
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
16.3
8.5
13
8
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
8.5
521
6644
B59
ICD-10 Finland
Pneumocystosis
20.0
8.5
12
6
WX702
NOMESCO Finland
Supraglottic ventilation device
1.8
8.4
143
811
C43
ICD-10 Finland
Malignant melanoma of skin
90.2
8.4
9
*
JN5AP
NOMESCO Finland
Total body PET (1 picture)
90.2
8.4
9
*
JN6CD
NOMESCO Finland
Very extensive CT of torso and neck
90.2
8.4
9
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.4
8.4
409
3000
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
12.8
8.4
14
11
KC1GB
NOMESCO Finland
Cystography with X-ray
12.8
8.4
14
11
ZQZ00
NOMESCO Finland
Treatment of several skin areas
7.8
8.3
18
23
JFB43
NOMESCO Finland
Left hemicolectomy
6.7
8.3
20
30
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
+∞
8.3
8
*
399
Kela drug reimbursment
Venetoclax
+∞
8.3
8
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
8.3
8
*
C83.7
ICD-10 Finland
Burkitt lymphoma
+∞
8.3
8
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
L01XE03
ATC
[U] erlotinib; oral
+∞
8.3
8
*
C43.00
ICD-10 Finland
Malignant melanoma of the lip without histology
+∞
8.3
8
*
1552X
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]
+∞
8.3
8
*
JN5AN
NOMESCO Finland
Total body isotope imaging
+∞
8.3
8
*
4CJ01
NOMESCO Finland
NA
+∞
8.3
8
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
9651/3-C77.8
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of multiple regions
+∞
8.3
8
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
8.3
8
*
C48.19
ICD-10 Finland
Malignant tumor in specified location in peritoneum other or unspecified histlogy
+∞
8.3
8
*
C43.90
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin without histology
+∞
8.3
8
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
+∞
8.3
8
*
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
+∞
8.3
8
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
8.3
8
*
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
+∞
8.3
8
*
9695/3-C77.2
ICD-O-3
Follicular lymphoma, grade 1 of intra-abdominal lymph nodes
+∞
8.3
8
*
8140/3-C18.3
ICD-O-3
Adenocarcinoma, NOS, of hepatic flexure of colon
+∞
8.3
8
*
C37
ICD-10 Finland
Malignant neoplasm of thymus
+∞
8.3
8
*
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
+∞
8.3
8
*
C83.4
ICD-10 Finland
Immunoblastic (diffuse) non-Hodgkin's lymphoma
+∞
8.3
8
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
8.3
8
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
8.3
8
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
8.3
8
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
+∞
8.3
8
*
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
+∞
8.3
8
*
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
+∞
8.3
8
*
155
Kela drug reimbursment
Afatinib and gefitinib
+∞
8.3
8
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
8.3
8
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.3
8
*
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
8.3
8
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
8.3
8
*
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
+∞
8.3
8
*
C18.4
ICD-10 Finland
Malignant neoplasm: Transverse colon
+∞
8.3
8
*
C16.0
ICD-10 Finland
Malignant neoplasm: Cardia
+∞
8.3
8
*
9590/3-C80.9
ICD-O-3
Malignant lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
8.3
8
*
2002A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma
+∞
8.3
8
*
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
+∞
8.3
8
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
8.3
8
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
8.3
8
*
1DB01
NOMESCO Finland
NA
+∞
8.3
8
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
8.3
8
*
U77
ICPC
Malignant neopl urinary tract other
+∞
8.3
8
*
R60.0
ICD-10 Finland
Localized oedema
1.4
8.3
376
2720
ZXC50
NOMESCO Finland
Cryotherapy
2.2
8.3
77
348
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
8.3
369
2660
F03
ICD-10 Finland
Unspecified dementia
0.5
8.3
77
1431
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
8.5
8.3
17
20
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
8.5
8.3
17
20
WX199
NOMESCO Finland
Other local analgesia
2.1
8.3
93
454
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
4.3
8.3
29
68
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
5.5
8.3
23
42
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
2.8
8.2
52
190
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
2.7
8.1
52
192
B04
ICPC
Blood symptom/complaint
5.4
8.1
23
43
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.2
8.1
40
126
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
33.4
8.1
10
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
17.2
8.1
12
7
5701
FHL
Local exploration of lymph nodes (includes biopsy)
17.2
8.1
12
7
JG1CG
NOMESCO Finland
Extensive MRI of rectum
11.7
8.1
14
12
7842A
ICD-9 Finland
Symptoms involving head and neck, Swelling, mass, or lump in head and neck
11.7
8.1
14
12
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.5
8.1
60
243
QAE30
NOMESCO Finland
Excision and repair of surgical scar in head or neck
22.0
8.0
11
5
WX725
NOMESCO Finland
Noninvasive ventilation
1.8
8.0
137
783
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
2.7
7.9
51
189
23999
ICD-8 Finland
Neoplasm of unspecified nature of other and unspecified organs, Other and unspecified sites
13.0
7.9
13
10
ZXC20
NOMESCO Finland
Use of chemical agents
2.8
7.9
47
168
ZZA50
NOMESCO Finland
Full thickness skin graft
7.7
7.9
17
22
J01CA04
ATC
amoxicillin; systemic
1.2
7.8
2992
27953
S04
ICPC
Lump/swelling localized
1.5
7.8
270
1854
ZXF10
NOMESCO Finland
Interruption caused by technical failure of equipment
10.8
7.8
14
13
R22.7
ICD-10 Finland
Localized swelling, mass and lump, multiple sites
9.4
7.8
15
16
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
9.4
7.8
15
16
Z31.8
ICD-10 Finland
Other procreative management
45.0
7.7
9
*
WF090
NOMESCO Finland
Profylactic radiotherapy
45.0
7.7
9
*
K56.7
ICD-10 Finland
Ileus, unspecified
2.6
7.7
54
212
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
3.2
7.7
38
120
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
4.2
7.7
27
64
N05BA04
ATC
oxazepam; oral
1.3
7.7
834
6871
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.6
7.7
53
205
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
3.2
7.6
37
115
SPAT1053
SPAT
Memory test
0.7
7.6
390
5097
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
0.4
7.6
24
653
J94.0
ICD-10 Finland
Chylous effusion
18.4
7.6
11
6
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
6.7
7.6
18
27
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
25.0
7.6
10
*
A02BC05
ATC
esomeprazole; systemic
1.2
7.6
1392
12142
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.3
7.6
509
3931
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
5.1
7.5
22
43
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
10.0
7.5
14
14
L04AD01
ATC
ciclosporin; systemic
2.5
7.5
54
216
D11.70
ICD-10 Finland
Gland sublingual
5.4
7.5
21
39
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
7.5
543
4239
TK800
NOMESCO Finland
Hemodialysis
2.1
7.5
81
393
JFC10
NOMESCO Finland
Ileotransversostomy
80.2
7.4
8
*
3AA02
NOMESCO Finland
NA
80.2
7.4
8
*
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
80.2
7.4
8
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
80.2
7.4
8
*
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
80.2
7.4
8
*
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
80.2
7.4
8
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
80.2
7.4
8
*
BA2AT
NOMESCO Finland
Biopsy of thyroid with ultrasound quidance
13.4
7.4
12
9
UGC02
NOMESCO Finland
Rigid bronchoscopy
7.6
7.4
16
21
9691/3-C77.2
ICD-O-3
Follicular lymphoma, grade 2 of intra-abdominal lymph nodes
+∞
7.3
7
*
C44.00
ICD-10 Finland
Malignant tumor of the lip skin without histology
+∞
7.3
7
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
7.3
7
*
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
7.3
7
*
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
+∞
7.3
7
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
7.3
7
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
7.3
7
*
9688/3-C77.8
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions
+∞
7.3
7
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
7.3
7
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
7.3
7
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
7.3
7
*
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
+∞
7.3
7
*
9688/3-C77.9
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS
+∞
7.3
7
*
9705/3-C77.8
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions
+∞
7.3
7
*
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
+∞
7.3
7
*
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
7.3
7
*
1CD01
NOMESCO Finland
NA
+∞
7.3
7
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
7.3
7
*
9687/3-C77.9
ICD-O-3
Burkitt lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
L01XE13
ATC
[U] afatinib; oral
+∞
7.3
7
*
C85
ICD-10 Finland
Other and unspecified types of non-Hodgkin lymphoma
+∞
7.3
7
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
7.3
7
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
7.3
7
*
C54.2
ICD-10 Finland
Malignant neoplasm: Myometrium
+∞
7.3
7
*
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
+∞
7.3
7
*
9823/3-C77.0
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of head, face and neck
+∞
7.3
7
*
C17.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of small intestine
+∞
7.3
7
*
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
+∞
7.3
7
*
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
+∞
7.3
7
*
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
+∞
7.3
7
*
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
+∞
7.3
7
*
8140/3-C23.9
ICD-O-3
Adenocarcinoma, NOS, of gallbladder
+∞
7.3
7
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
+∞
7.3
7
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
7.3
7
*
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
+∞
7.3
7
*
316
Kela drug reimbursment
Imatinib
+∞
7.3
7
*
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
7.3
7
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
+∞
7.3
7
*
L02BB01
ATC
flutamide; oral
+∞
7.3
7
*
L01XX52
ATC
venetoclax; oral
+∞
7.3
7
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
+∞
7.3
7
*
C16.2
ICD-10 Finland
Malignant neoplasm: Body of stomach
+∞
7.3
7
*
9659/3-C77.4
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of inguinal region or leg
+∞
7.3
7
*
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
7.3
7
*
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
+∞
7.3
7
*
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
+∞
7.3
7
*
C08.89
ICD-10 Finland
Malignant overall tumor the large salivary glands anna or unspecified histology
+∞
7.3
7
*
9650/3-C77.3
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of axilla or arm
+∞
7.3
7
*
C76.3
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Pelvis
+∞
7.3
7
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
2.5
7.3
52
207
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
9.4
7.3
14
15
XX9XW
NOMESCO Finland
NA
4.5
7.2
24
54
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
5.8
7.2
19
33
GAC00
NOMESCO Finland
Biopsy of pleura
4.6
7.2
23
50
N63
ICD-10 Finland
Unspecified lump in breast
1.8
7.2
114
639
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
7.3
7.2
16
22
D36.0
ICD-10 Finland
Benign neoplasm: Lymph nodes
30.0
7.1
9
*
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
30.0
7.1
9
*
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
20.0
7.1
10
5
E0000UV
ATC
NA
1.2
7.1
1275
11083
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.7
7.1
196
2830
J01MA01
ATC
ofloxacin; systemic
1.4
7.1
314
2265
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.2
7.1
34
106
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
5.3
7.1
20
38
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
4.0
7.1
26
65
A01AB10
ATC
natamycin; local oral
1.9
7.0
95
504
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.9
7.0
90
466
K85
ICPC
Elevated blood pressure
0.7
7.0
311
4151
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.2
7.0
34
107
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
4.9
7.0
21
43
ZZA00
NOMESCO Finland
Split skin graft
2.0
6.9
83
417
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.1
6.9
69
324
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
13.8
6.9
11
8
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.8
6.9
406
5209
RS221
NOMESCO Finland
NA
2.6
6.9
48
187
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
6.8
1189
10295
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
2.4
6.8
52
214
SPAT1111
SPAT
Planning of analgesia
2.7
6.8
44
164
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
6.8
268
1891
WX720
NOMESCO Finland
Own respiration
1.8
6.8
116
664
K31.5
ICD-10 Finland
Obstruction of duodenum
8.3
6.8
14
17
TGA30
NOMESCO Finland
Thoracocentesis
3.2
6.8
33
104
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
3.2
6.8
33
104
153
Kela drug reimbursment
Lenalidomid
40.1
6.8
8
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
40.1
6.8
8
*
XX1XN
NOMESCO Finland
Other isotope examination
40.1
6.8
8
*
2301
FHL
Lumbar puncture in anesthesia or operating room
40.1
6.8
8
*
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
40.1
6.8
8
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
40.1
6.8
8
*
U75
ICPC
Malignant neoplasm of kidney
40.1
6.8
8
*
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
2.9
6.7
39
136
ZX100
NOMESCO Finland
Oral
2.7
6.7
42
156
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
16.7
6.7
10
6
TKE10
NOMESCO Finland
Puncture of prostate
22.5
6.7
9
*
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
22.5
6.7
9
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
6.7
187
1225
UJC02
NOMESCO Finland
Rigid oesophagoscopy
3.0
6.6
35
117
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
4.4
6.6
22
50
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.8
6.6
39
139
9109
FHL
Other measure in this category
6.4
6.6
16
25
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.4
6.6
349
2596
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
7.8
6.6
14
18
B37.7
ICD-10 Finland
Candidal sepsis
7.8
6.6
14
18
KBV00
NOMESCO Finland
Insertion of stent into ureter
4.2
6.6
23
55
L04AA06
ATC
mycophenolic acid; systemic
2.4
6.6
51
214
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
1.8
6.5
98
538
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
2.2
6.5
59
267
DAB00
NOMESCO Finland
Excision of lesion of auricle
3.9
6.5
24
61
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.5
6.5
59
1098
R13
ICD-10 Finland
Dysphagia
1.5
6.4
207
1400
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
6.4
216
1477
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
69.9
6.4
7
*
D73.0
ICD-10 Finland
Hyposplenism
69.9
6.4
7
*
D74
ICPC
Malignant neoplasm stomach
69.9
6.4
7
*
Z92.3
ICD-10 Finland
Personal history of irradiation
69.9
6.4
7
*
JJB30
NOMESCO Finland
Excision of two segments of liver
69.9
6.4
7
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
69.9
6.4
7
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
69.9
6.4
7
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
69.9
6.4
7
*
JM2AT
NOMESCO Finland
Biopsy of spleen with ultrasound guidance
69.9
6.4
7
*
L04.9
ICD-10 Finland
Acute lymphadenitis, unspecified
7.4
6.4
14
19
R96
ICPC
Asthma
0.6
6.4
130
1991
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
14.3
6.4
10
7
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.9
6.4
83
432
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
4.9
6.3
19
39
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
4.4
6.3
21
48
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
3.4
6.3
28
83
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.3
6.3
52
225
B29
ICPC
Lymph/immune mech sympt/complt other
5.5
6.3
17
31
I88.8
ICD-10 Finland
Other nonspecific lymphadenitis
9.2
6.3
12
13
OAB42
SPAT
NA
0.5
6.3
49
955
H61.2
ICD-10 Finland
Impacted cerumen
0.6
6.3
77
1321
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
4.0
6.3
23
58
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
18.0
6.3
9
5
R85
ICPC
Malignant neopl respiratory other
18.0
6.3
9
5
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
6.2
6
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
6.2
6
*
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
+∞
6.2
6
*
C84.42
ICD-10 Finland
Peripheral T-cell lymphoma, both medium and large cell type
+∞
6.2
6
*
2014X
ICD-9 Finland
Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,LYMPHOCYTIC PREDOMINANCE"""",NUD]
+∞
6.2
6
*
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.2
6
*
20018
ICD-8 Finland
Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco non indicato sive generalisatum
+∞
6.2
6
*
PJ003
NOMESCO Finland
Adjuvant radiotherapy of neck, clavicle and axilla
+∞
6.2
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.2
6
*
3AF07
NOMESCO Finland
NA
+∞
6.2
6
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
6.2
6
*
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
+∞
6.2
6
*
PJ3HT
NOMESCO Finland
Cytology of deep lymphnode with ultrasound guidance
+∞
6.2
6
*
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
+∞
6.2
6
*
L01XB01
ATC
procarbazine; oral
+∞
6.2
6
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
6.2
6
*
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
+∞
6.2
6
*
QA7S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in jaw or lips
+∞
6.2
6
*
C779, 9715, 3
ICD-O-3
NA
+∞
6.2
6
*
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
6.2
6
*
C18.50
ICD-10 Finland
Malignant tumor in flexural lienalis without histology
+∞
6.2
6
*
9698/3-C77.4
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of inguinal region or leg
+∞
6.2
6
*
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
+∞
6.2
6
*
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
+∞
6.2
6
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
6.2
6
*
C16.23
ICD-10 Finland
Malignant tumor of the corpus ventriculi diffuse carcinoma
+∞
6.2
6
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
6.2
6
*
5BX04
NOMESCO Finland
NA
+∞
6.2
6
*
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.2
6
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
6.2
6
*
C48.80
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum without histology
+∞
6.2
6
*
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
+∞
6.2
6
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
6.2
6
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
6.2
6
*
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
+∞
6.2
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.2
6
*
8000/3-C76.1
ICD-O-3
Neoplasm, malignant of thorax, NOS
+∞
6.2
6
*
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
+∞
6.2
6
*
C44.99
ICD-10 Finland
Unspecified localization of malignant tumor in skin other or unspecified histology
+∞
6.2
6
*
V03AB28
ATC
NA
+∞
6.2
6
*
C18.3
ICD-10 Finland
Malignant neoplasm: Hepatic flexure
+∞
6.2
6
*
323
Kela drug reimbursment
Sorafenib
+∞
6.2
6
*
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
+∞
6.2
6
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
6.2
6
*
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
+∞
6.2
6
*
9690/3-C77.3
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of axilla or arm
+∞
6.2
6
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
6.2
6
*
8140/3-C15.9
ICD-O-3
Adenocarcinoma, NOS, of esophagus, NOS
+∞
6.2
6
*
8140/3-C25.0
ICD-O-3
Adenocarcinoma, NOS, of head of pancreas
+∞
6.2
6
*
20228
ICD-8 Finland
Other neoplasms of lymphoid tissue, Other primary malignant neoplasms of lymphoid tissue
+∞
6.2
6
*
8500/3-C25.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of pancreas, NOS
+∞
6.2
6
*
C18.1
ICD-10 Finland
Malignant neoplasm: Appendix
+∞
6.2
6
*
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
+∞
6.2
6
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
6.2
6
*
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
6.2
6
*
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
+∞
6.2
6
*
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
+∞
6.2
6
*
C44.01
ICD-10 Finland
Basocellular carcinoma of the lip skin
+∞
6.2
6
*
9670/3-C77.4
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of inguinal region or leg
+∞
6.2
6
*
2017X
ICD-9 Finland
Hodgkin's disease, Lymphocytic depletion[MORBUS HODGKIN, LYMPHOCYTIC DEPLETION NUD]
+∞
6.2
6
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.2
6
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
3.1
6.2
31
100
7323
FHL
Electrosection of TU bladder wall change
26.7
6.2
8
*
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
4.3
6.2
21
49
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
3.2
6.2
30
95
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.5
6.2
57
1055
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
3.6
6.2
25
69
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
2.3
6.2
54
241
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
5.3
6.1
17
32
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.3
6.1
476
3753
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.5
6.1
45
184
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
7.7
6.1
13
17
A10AA02
ATC
NA
0.5
6.1
43
863
J45
ICD-10 Finland
Asthma
0.7
6.0
137
2052
K65.0
ICD-10 Finland
Acute peritonitis
2.5
6.0
43
170
JLC10
NOMESCO Finland
Distal pancreatectomy
8.6
6.0
12
14
HAE99
NOMESCO Finland
Other reconstruction of breast
10.0
6.0
11
11
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
10.0
6.0
11
11
D73.1
ICD-10 Finland
Hypersplenism
10.0
6.0
11
11
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.6
6.0
149
952
M25.5
ICD-10 Finland
Pain in joint
0.8
6.0
601
7249
L15
ICPC
Knee symptom/complaint
0.8
6.0
443
5527
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494815) CD4 cells/100 lymphocytes in Specimen
512
637
7.22
323.31
2.1
2.1
%
29.5
45.5
7.32
42
95
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
553
758
6.56
319.88
1.5
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
12649
132317
0.55
318.51
5.9
6.3
mmol/mol
41.3
40.4
17.13
11307
121765
(3004789) Transferrin [Mass/volume] in Serum or Plasma
4117
19779
2.05
318.50
2.1
2.6
g/l
2.2
2.3
25.21
3892
18084
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
626
981
5.76
317.49
1.3
1.3
u/l
445.6
409.7
0.22
593
913
(3025159) Blasts/100 leukocytes in Blood
2483
9782
2.41
312.77
3.9
3.9
%
0.1
0.2
0.11
1277
1828
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
2763
11431
2.31
311.27
3.3
2.3
u/l
38.3
43.0
0.45
2454
9658
(3018010) Neutrophils/100 leukocytes in Blood
11318
61995
2.43
307.65
7.0
5.7
%
60.4
57.5
92.52
10859
57271
(3003694) ABO and Rh group [Type] in Blood
6193
31906
2.03
307.65
1.4
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
197
15
116.49
307.65
1.0
1.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
934
1481
5.77
307.65
1.4
1.5
g/l
36.6
30.1
36.04
871
1298
(3013650) Neutrophils [#/volume] in Blood by Automated count
15362
72307
5.02
307.65
25.5
6.5
e9/l
4.0
4.3
28.23
14367
61789
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
838
1505
5.06
307.65
2.2
2.8
u/ml
13764.8
7324.4
0.27
75
81
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
13217
139072
0.49
307.65
3.9
4.8
mmol/l
4.6
4.6
3.02
11613
128266
(3033658) Prothrombin time (PT) actual/Normal
6985
32029
2.42
307.65
6.1
3.6
%
87.8
87.7
0.05
6877
31135
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
3766
15196
2.46
307.65
2.0
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
1264
2577
4.54
307.65
1.7
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
3617
15527
2.28
307.65
6.8
7.1
mmol/l
1.3
1.3
0.14
2922
12098
(3021879) Hepatitis B virus core Ab [Presence] in Serum
2287
6861
3.18
307.65
1.3
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
3959
18452
2.11
307.65
2.2
2.7
%
20.7
22.7
12.46
3456
15431
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
4031
10199
4.11
307.65
2.6
2.1
g/l
0.2
0.2
18.97
3830
9243
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
1033
1905
4.97
307.65
1.7
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
526
529
8.95
307.65
2.1
2.0
%
14.7
15.4
0.31
192
241
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
1042
1964
4.86
307.65
3.9
6.0
iu/ml
2288.7
856.4
0.38
127
297
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
3143
12416
2.46
307.65
1.4
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
776
917
7.70
307.65
1.4
1.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
531
543
8.80
307.65
2.1
2.0
%
72.5
72.1
0.17
509
517
(3042111) Morphology [Interpretation] in Bone marrow Narrative
840
1601
4.77
307.65
1.5
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
6876
30631
2.50
307.65
19.8
4.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
523
498
9.45
307.65
2.1
2.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
4882
21088
2.38
307.65
2.3
1.9
s
29.7
29.9
1.75
4772
20424
(3006504) Eosinophils/100 leukocytes in Blood
11525
60973
2.60
307.65
7.2
5.7
%
2.5
3.0
89.40
11057
56108
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
16641
103695
3.73
307.65
23.7
5.5
u/l
107.1
76.0
261.70
16346
95832
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
870
196
40.75
307.65
1.3
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
827
1246
6.04
307.65
1.2
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
8087
7529
15.37
307.65
7.3
1.5
ug/l
70.3
8.7
15.60
7249
5669
(3002173) Hemoglobin [Mass/volume] in Arterial blood
3014
12626
2.30
307.65
7.4
8.0
g/l
114.9
122.8
80.90
2911
12149
(3018095) Leukocytes [#/volume] in Urine
8317
47697
1.92
307.65
4.2
3.5
e6/l
140.4
109.6
1.28
6687
33397
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
3832
13883
2.77
307.65
4.3
2.3
umol/l
15.3
7.8
25.86
3466
11900
(40768795) Lymph node Pathology biopsy report
1195
278
40.14
307.65
1.4
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
7499
19648
4.81
307.65
5.8
2.6
mmol/l
0.8
0.8
79.22
7268
17934
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7793
41534
2.08
307.65
6.9
2.7
u/l
43.4
34.4
5.58
7513
38967
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
1374
3691
3.44
307.65
1.7
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
1523
4433
3.19
307.65
5.5
2.7
g/l
0.2
0.3
11.87
1127
1568
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
1117
138
75.32
307.65
7.3
1.1
u/ml
96.9
20.3
16.90
1109
129
(3002030) Lymphocytes/100 leukocytes in Blood
11712
62752
2.59
307.65
7.4
5.8
%
23.4
27.6
246.84
11213
57677
(3002256) Pathology report gross observation
3508
10905
3.22
307.65
1.4
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
1161
1203
8.95
307.65
2.7
2.0
u/ml
581.6
785.2
0.14
1142
1166
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
5558
21918
2.71
307.65
2.1
1.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
331
179
16.50
307.65
1.2
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
6826
29112
2.63
307.65
3.3
2.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
4160
16641
2.52
307.65
7.8
6.7
mmol/l
104.0
104.3
3.03
4069
16208
(3018418) pH of Serum or Plasma
8862
39679
2.76
307.65
7.1
3.3
ph
7.4
7.4
4.46
2406
6928
(40768441) Liver Pathology biopsy report
743
563
12.01
307.65
1.1
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
9335
44097
2.64
307.65
2.7
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
7007
37384
2.01
307.65
3.5
3.0
e6/l
0.7
0.4
6.11
5701
27821
(3044640) Blood type and Crossmatch panel - Blood
9177
37974
3.11
307.65
3.4
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
2926
9216
3.10
307.65
1.8
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
12537
61686
3.18
307.65
9.1
5.4
mmol/l
1.2
1.2
4.20
12064
54629
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
2286
7695
2.82
307.65
1.7
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
653
746
7.92
307.65
1.2
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
2628
9797
2.57
307.65
3.7
3.6
%
0.9
0.5
8.86
1157
1665
(3010503) CD19 cells [#/volume] in Blood
455
484
8.43
307.65
2.5
2.3
e9/l
0.3
0.2
0.19
447
464
(3001604) Monocytes [#/volume] in Blood
11779
65760
2.44
307.65
7.1
5.5
e9/l
0.6
0.6
11.39
10398
56241
(42870588) Differential panel, method unspecified - Blood
9284
44363
2.59
307.65
7.0
5.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
2809
10265
2.64
307.65
3.8
3.8
%
0.2
0.1
13.59
1568
2098
(3006315) Basophils [#/volume] in Blood
11833
66149
2.44
307.65
7.1
5.5
e9/l
0.0
0.0
46.77
10457
56590
(3011412) CD3 cells [#/volume] in Blood
658
739
8.06
307.65
2.4
2.1
e9/l
1.0
1.1
1.27
451
397
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
2407
5138
4.55
307.65
2.1
1.9
ug/l
2.6
2.1
0.36
2222
4478
(3036481) Cortisol [Moles/volume] in Serum or Plasma
2833
11089
2.45
307.65
4.9
1.8
nmol/l
402.8
366.5
14.28
2719
10036
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
1177
745
14.70
307.65
5.2
1.6
nmol/l
15.8
4.3
1.76
1168
710
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
15674
65781
6.48
307.65
20.5
3.8
umol/l
11.3
11.9
4.13
15446
61434
(3019069) Monocytes/100 leukocytes in Blood
11608
61289
2.63
307.65
7.4
6.0
%
9.1
8.7
21.08
11155
56668
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
11881
57807
3.05
307.65
5.9
3.7
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
1651
720
21.90
307.65
2.4
1.3
ug/l
29.1
24.5
0.52
1623
699
(3035637) Corticotropin [Mass/volume] in Plasma
801
1102
6.61
307.65
1.7
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
2308
1645
13.83
307.65
5.1
1.9
u/ml
1400.6
687.1
0.90
2126
1478
(40760892) CBC W Ordered Manual Differential panel - Blood
5474
27722
2.02
307.65
5.8
4.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
3119
10865
2.81
307.65
6.9
3.0
mmol/l
1.2
1.2
0.18
3016
9160
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
8945
48335
2.15
307.65
3.6
3.2
—
0.6
—
0
10
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
13809
68284
3.63
307.65
11.1
5.8
mmol/l
1.2
1.2
9.86
11426
57320
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
2146
7541
2.68
307.65
5.8
7.4
mmol/l
24.9
24.8
0.23
2130
7455
(3003458) Phosphate [Moles/volume] in Serum or Plasma
4196
16982
2.49
307.65
5.4
5.5
mmol/l
1.0
1.0
3.44
3999
15607
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
1696
4195
3.79
307.65
2.7
3.2
u/ml
0.4
0.4
0.12
1013
2483
(3023199) Leukocytes [#/volume] in Pleural fluid
787
1333
5.36
307.65
1.4
1.5
e6/l
1880.5
3609.4
1.42
588
985
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
3762
15221
2.45
307.65
2.0
1.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
711
1195
5.38
307.65
1.4
1.5
e6/l
47874.7
57979.8
0.41
437
725
(3026008) Bacteria identified in Urine by Culture
7479
41446
1.95
307.65
3.5
3.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
3602
15557
2.27
307.65
6.8
7.1
kpa
13.4
11.7
54.65
3429
14796
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
3317
2803
12.31
307.65
5.5
2.0
u/ml
3327.6
138.3
3.46
2963
2275
(3012441) Differential panel - Pleural fluid
701
1112
5.70
307.65
1.4
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
4769
18316
2.70
307.65
2.0
2.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
3246
13985
2.24
307.65
7.1
7.5
%
96.0
95.2
8.25
3117
13451
(40768800) Prostate Pathology biopsy report
661
929
6.43
307.65
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
296
116
22.74
307.65
9.4
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
2531
4239
5.87
307.65
7.8
1.5
u/ml
141.0
28.0
22.47
2486
4038
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
1680
1847
8.64
307.65
1.3
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
11300
59206
2.60
307.65
7.2
5.8
%
0.6
0.7
39.48
10842
54548
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
6516
24125
3.06
307.65
8.1
2.2
mmol/l
2.5
2.4
107.81
6203
20511
(3000850) Epithelial cells [#/volume] in Urine
5541
28226
2.01
307.65
2.8
2.5
e6/l
6.0
5.1
4.36
5019
24414
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
13566
142058
0.47
307.65
4.2
5.3
mmol/l
2.7
2.7
1.28
11812
130469
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
13023
137923
0.49
307.65
3.8
4.7
mmol/l
1.4
1.5
44.95
11410
126420
(3023368) Bacteria identified in Blood by Culture
10388
35615
4.33
307.65
5.9
4.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
1295
2359
5.09
307.65
1.4
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
458
399
10.30
307.65
2.8
3.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
13534
89577
2.06
307.65
5.2
4.4
e6/l
815.1
1514.6
1.04
302
1350
(4281824)
618
677
8.24
307.65
1.2
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
770
1035
6.76
307.65
1.5
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
13633
81315
2.56
307.65
6.9
4.4
mmol/l
6.9
6.8
1.38
13245
75734
(3019198) Lymphocytes [#/volume] in Blood
11979
67570
2.44
307.65
7.2
5.6
e9/l
1.7
1.9
12.52
10709
58871
(3017143) Hepatitis C virus Ab [Presence] in Serum
3009
11122
2.63
307.65
1.4
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
3604
15567
2.27
307.65
6.8
7.1
kpa
5.1
5.1
1.38
3433
14812
(4035726)
6471
4079
20.32
307.65
1.6
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
733
792
8.40
307.65
1.3
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
1292
2683
4.46
307.65
1.7
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
429
39
98.74
307.65
1.1
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
7844
40673
2.16
307.65
3.6
3.0
e6/l
96.5
95.5
0.02
6482
30828
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
6197
13188
5.57
307.65
6.3
2.7
u/l
271.0
240.9
19.75
6017
12222
(3026782) Osmolality of Urine
5573
26064
2.23
307.65
3.2
2.7
mosm/kgh2o
541.3
545.7
0.79
5026
21779
(3024561) Albumin [Mass/volume] in Serum or Plasma
13225
56872
4.21
307.65
9.5
3.8
g/l
32.6
35.6
307.65
12783
51868
(3020779) Urea [Moles/volume] in Serum or Plasma
3250
11773
2.71
307.65
6.3
7.3
mmol/l
8.7
10.7
42.95
3114
11125
(3017181) Myelocytes/100 leukocytes in Blood
3106
10660
2.85
307.65
3.8
3.8
%
1.3
0.8
18.05
1727
2254
(3015377) Calcium [Moles/volume] in Serum or Plasma
10469
42497
3.50
307.65
10.9
2.1
mmol/l
2.3
2.4
5.36
9900
35357
(3013115) Eosinophils [#/volume] in Blood
12047
68321
2.43
307.65
7.4
5.7
e9/l
0.2
0.2
75.99
10727
59337
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
1449
202
67.95
307.65
7.9
1.1
u/ml
88.0
25.7
9.27
1421
185
(3032080) INR in Blood by Coagulation assay
11966
56905
3.18
307.65
9.1
9.8
inr
1.2
1.3
21.70
3511
15748
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1583
4242
3.48
307.65
2.3
2.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
8908
43011
2.50
307.65
4.3
2.3
u/l
54.3
59.9
14.24
8473
39229
(36304419) Bacteria [Presence] in Urine
6604
35942
1.93
307.65
3.4
2.9
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
1077
1612
6.15
307.65
2.8
2.9
%
2.0
1.3
5.65
864
1216
(3027945) Reticulocytes/100 erythrocytes in Blood
3403
15408
2.14
306.91
2.7
2.2
%
1.9
1.8
4.47
3104
13380
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
12821
133239
0.55
306.11
3.6
4.2
mmol/l
1.4
1.3
18.64
11187
121137
(3022948) Iron [Moles/volume] in Serum or Plasma
4320
21487
1.98
301.12
2.2
2.5
umol/l
11.2
13.0
42.62
4096
19658
(3014111) Lactate [Moles/volume] in Serum or Plasma
2752
11554
2.27
298.60
6.0
6.9
mmol/l
1.4
1.4
0.36
2656
11104
(3000991) Gas panel - Venous blood
2640
10936
2.29
295.47
7.1
8.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
9299
58920
1.74
292.69
19.1
8.6
e9/l
0.0
0.0
6.00
7789
48222
(3042631) Mycobacterium sp identified in Specimen
806
1694
4.31
291.63
1.9
2.8
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
600
998
5.41
285.63
1.3
1.3
mmol/l
6.0
6.7
4.95
559
916
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2262
39159
0.44
285.15
1.6
1.7
mmol/l
1.5
1.4
10.68
1889
32418
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
3044
13583
2.15
282.97
5.1
3.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
758
1561
4.40
281.35
1.6
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
298
214
12.40
280.12
2.0
2.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
846
1917
4.01
277.06
1.6
1.4
pmol/l
386.7
76.3
14.32
826
1877
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
894
2128
3.82
273.44
1.5
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
321
275
10.40
269.93
2.0
2.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
324
286
10.10
266.97
2.0
2.1
%
8.2
8.9
0.32
319
275
(3045788) Cell count panel - Pleural fluid
586
1023
5.15
264.47
1.5
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
2628
11365
2.19
262.96
3.5
1.6
g/l
64.4
66.9
43.23
2469
10149
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
645
1242
4.68
259.86
1.6
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
371
413
8.02
257.08
3.3
2.6
%
36.2
42.5
3.53
123
147
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
167
34
43.49
252.62
7.6
2.9
umol/l
0.4
0.5
0.24
160
19
(3002032) Base excess in Venous blood by calculation
2885
13145
2.09
251.57
3.9
3.8
mmol/l
2.2
1.9
2.23
2331
10757
(3012544) pH of Venous blood
2973
13710
2.07
250.98
3.8
3.8
ph
7.4
7.4
0.14
16
60
(3021447) Carbon dioxide [Partial pressure] in Venous blood
2883
13170
2.08
249.50
3.8
3.8
kpa
5.7
5.9
12.94
2806
12774
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
735
1626
4.09
248.34
1.5
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
1221
3773
2.96
246.79
1.3
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
791
1869
3.83
244.16
1.5
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
4068
21168
1.87
240.55
3.3
2.7
e6/l
2.5
2.8
0.78
2506
11366
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
739
1691
3.95
238.45
1.5
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
422
596
6.33
237.03
2.6
2.2
e6/l
433.2
921.5
2.22
159
274
(3008757) Leukocyte morphology finding [Identifier] in Blood
601
1190
4.54
233.93
3.1
3.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
3092
14810
1.99
233.54
1.5
1.7
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
1069
3171
3.07
231.72
2.2
2.5
g/l
3.8
3.6
4.34
1036
3008
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1788
6919
2.40
230.83
8.8
10.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
467
756
5.53
228.62
1.2
1.3
u/l
13.1
12.5
0.16
439
684
(3014007) Fractional oxyhemoglobin in Arterial blood
2018
8268
2.27
228.39
7.9
9.3
%
94.4
93.4
11.27
2009
8241
(3012501) Base excess in Blood by calculation
1016
3020
3.06
219.25
4.2
4.0
mmol/l
2.8
2.5
1.49
747
2054
(3013290) Carbon dioxide [Partial pressure] in Blood
1016
3022
3.06
218.99
4.2
4.0
kpa
5.0
5.0
1.29
1001
2937
(3023520) Reticulocytes [#/volume] in Blood
2527
11522
2.06
217.60
3.0
2.2
e9/l
70.8
69.4
0.99
1980
8754
(3027315) Oxygen [Partial pressure] in Blood
1018
3045
3.04
217.28
4.2
4.1
kpa
8.7
8.4
3.66
1003
2959
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
387
562
6.15
211.54
2.6
2.1
e6/l
525.7
505.0
0.11
322
480
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1971
8260
2.22
210.41
7.8
9.2
%
0.7
0.7
0.79
1954
8206
(3017446) Testosterone [Moles/volume] in Serum or Plasma
1968
8271
2.21
208.53
2.3
2.2
nmol/l
6.4
14.5
246.68
1672
7263
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
1485
5541
2.46
206.80
2.3
1.8
—
—
—
0
0
(3035880) pH of Pleural fluid
395
612
5.76
202.34
1.3
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
529
1063
4.46
202.04
1.8
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
553
1155
4.30
201.16
1.8
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
314
384
7.28
201.04
1.4
1.4
%
62.4
62.8
0.06
268
305
(3037467) Urinalysis macro (dipstick) panel - Urine
13034
95000
1.61
200.35
5.6
4.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
834
2325
3.25
200.06
1.6
1.3
u/l
15.8
9.6
18.57
689
1859
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
367
536
6.11
199.47
2.7
2.1
e9/l
0.2
0.2
0.06
318
474
(3010421) pH of Blood
1082
3511
2.81
199.21
4.2
4.0
ph
7.4
7.4
2.55
1002
2937
(3021162) Amylase [Enzymatic activity/volume] in Specimen
177
91
17.23
198.11
2.8
2.7
u/l
1099.1
2915.5
0.49
156
80
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1943
8333
2.16
195.12
7.8
9.0
%
1.3
1.4
3.03
1925
8272
(3013727) Leukocytes other/100 leukocytes in Blood
272
292
8.28
193.96
2.6
3.4
%
55.2
56.9
0.47
266
278
(3017354) Segmented neutrophils/100 leukocytes in Blood
524
1091
4.31
191.33
2.9
2.7
%
59.0
60.9
0.85
324
704
(3008152) Bicarbonate [Moles/volume] in Arterial blood
2046
9045
2.10
189.74
7.3
7.1
mmol/l
24.8
24.6
0.87
1926
8416
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
8532
56821
1.56
189.71
4.2
3.8
ng/l
36.2
77.0
5.95
7138
40430
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1884
8074
2.16
189.28
1.9
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
2123
9549
2.07
187.94
5.2
4.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
474
936
4.53
184.92
1.6
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
486
983
4.43
184.05
1.8
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
486
983
4.43
184.05
1.8
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
486
983
4.43
184.05
1.8
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
2012
8957
2.08
182.82
3.1
2.3
g/l
9.4
10.8
33.01
1865
8122
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
5690
34698
1.62
182.33
2.0
2.3
mg/l
3.5
2.9
35.94
4970
29392
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
321
450
6.35
181.51
9.0
1.2
u/ml
187.4
270.9
0.55
123
98
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
1346
5099
2.42
180.63
2.1
1.8
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
200
156
11.36
178.68
8.3
1.4
u/l
55.6
81.3
0.49
79
65
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
427
796
4.79
178.49
1.4
1.5
u/l
11.9
13.4
3.31
411
764
(3023183) Ammonium ion [Moles/volume] in Plasma
899
2807
2.90
177.32
2.0
2.6
umol/l
37.4
33.1
3.83
707
2387
(1616796) Gas panel - Central venous blood
928
2961
2.84
175.92
3.5
3.7
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
272
329
7.35
175.79
1.3
1.4
%
2.3
2.6
0.18
234
268
(40761536) Microorganisms panel - Urine sediment
2277
10806
1.96
172.67
4.9
4.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
287
381
6.70
170.77
1.4
2.3
e6/l
4470.9
2220.5
0.42
198
264
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
351
577
5.42
168.95
1.7
1.4
mg/l
3.6
3.8
0.21
334
547
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
367
638
5.13
166.17
1.6
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1681
7253
2.13
165.01
3.1
2.6
e6/l
0.4
0.3
2.67
1660
7062
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
398
749
4.74
164.50
1.6
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
364
635
5.11
164.17
1.6
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
708
2021
3.15
163.02
1.3
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
255
315
7.19
161.83
1.4
2.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
14051
137632
0.63
160.68
4.7
4.9
mmol/l
6.1
6.0
16.05
12516
124837
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
4040
23360
1.65
156.03
3.1
2.6
e6/l
2.1
1.1
0.84
2466
13455
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
6878
45036
1.53
155.66
3.1
3.1
ng/l
1462.9
1493.9
0.22
6210
38585
(44806118)
517
1244
3.72
155.03
1.5
1.5
—
—
—
0
0
(44790048)
517
1245
3.72
154.85
1.5
1.5
—
—
—
0
0
(44790047)
517
1245
3.72
154.85
1.5
1.5
—
—
—
0
0
(44790049)
517
1245
3.72
154.85
1.5
1.5
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
254
334
6.75
152.46
1.4
2.2
e6/l
12686.0
15291.3
0.13
143
169
(3024354) Oxygen [Partial pressure] in Venous blood
2239
11016
1.89
151.16
3.5
3.2
kpa
4.5
4.5
0.44
2161
10652
(3000919) Neutrophils/100 leukocytes in Pleural fluid
241
302
7.08
151.04
1.3
1.4
%
19.4
22.8
0.86
221
268
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
609
1677
3.26
148.65
5.4
6.2
mg/l
11.6
11.9
0.86
557
1524
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
273
399
6.08
148.25
2.1
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1566
6843
2.10
148.11
8.2
9.3
mmol/l
24.5
24.5
0.17
1493
6211
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
270
392
6.12
147.59
2.1
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
270
393
6.10
147.22
2.1
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
2905
15630
1.74
145.55
1.8
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
313
540
5.16
142.92
2.0
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
313
540
5.16
142.92
2.0
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
313
540
5.16
142.92
2.0
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
632
1823
3.11
142.85
1.3
1.5
u/ml
111.0
117.4
0.50
153
401
(3019225) pH of Specimen
2666
14076
1.77
142.41
7.6
3.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
313
542
5.14
142.33
2.0
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
206
231
7.90
141.85
2.8
1.4
u/l
43.7
36.7
0.22
199
206
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
215
265
7.19
136.72
2.2
1.9
%
35.3
26.4
9.44
198
251
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
17015
136550
1.72
136.08
35.4
13.2
mg/l
34.3
23.6
265.35
16190
106891
(3027273) Bicarbonate [Moles/volume] in Venous blood
1596
7275
2.01
134.09
3.8
3.4
mmol/l
25.2
25.3
0.93
1562
7053
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
213
266
7.10
133.91
1.2
1.3
ug/l
422.2
37.0
3.80
147
125
(40767503) Oxygen content in Capillary blood by calculation
831
2890
2.59
132.84
2.5
2.5
%
15.1
16.5
13.96
378
1509
(3007930) Methemoglobin/Hemoglobin.total in Blood
1360
5879
2.11
131.81
6.0
4.8
%
0.9
0.9
0.35
1276
5528
(3006245) CD3-CD19+ cells/100 cells in Blood
210
264
7.05
131.25
2.2
2.0
%
9.3
9.0
0.13
184
246
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
1374
5975
2.10
131.08
5.9
4.7
%
1.6
1.7
0.82
1287
5625
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
817
2842
2.59
130.51
1.5
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
1085
4318
2.28
129.07
6.6
5.7
mmol/l
1.4
1.3
0.71
957
3833
(3023383) Lactate [Moles/volume] in Pleural fluid
228
326
6.20
126.51
1.2
1.4
mmol/l
3.5
3.3
0.24
217
293
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
214
287
6.61
126.17
1.2
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
221
309
6.34
125.30
1.4
2.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
177
194
8.08
124.16
2.6
2.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
1003
3928
2.31
123.80
1.4
1.4
ug/g
219.2
283.1
18.08
628
2309
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
80
17
41.49
119.62
1.1
1.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1813
9008
1.85
117.04
3.7
3.6
kpa
5.1
5.2
2.81
1678
8265
(3018405) Lactate [Moles/volume] in Arterial blood
1183
5097
2.10
115.23
4.1
4.3
mmol/l
1.5
1.4
1.12
1151
4996
(3009343) pH of Capillary blood
1788
8887
1.84
115.20
3.7
3.6
ph
7.4
7.4
0.70
265
1089
(3028026) IgM [Mass/volume] in Serum or Plasma
1504
7070
1.94
115.00
2.2
1.5
g/l
1.2
1.2
0.14
1375
6403
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
151
149
8.96
114.88
1.2
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
880
3371
2.35
114.12
2.1
2.1
%
89.0
90.4
0.97
863
3114
(3028271) Lactate [Moles/volume] in Capillary blood
649
2151
2.71
113.98
1.9
1.9
mmol/l
1.8
1.7
1.01
636
2102
(3037692) Legionella sp identified in Specimen by Organism specific culture
235
385
5.41
113.55
1.2
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1731
8579
1.85
112.44
3.7
3.5
mmol/l
2.1
1.8
1.97
1312
6329
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
111
0
+∞
110.06
1.1
0.0
—
—
—
0
0
(3013512) EKG study
6319
42899
1.43
108.57
4.6
4.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
405
1056
3.42
107.66
1.6
1.3
u/l
33.6
31.4
0.60
384
796
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
813
3094
2.36
106.92
2.2
2.4
%
226.1
189.9
19.91
783
2905
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
820
3135
2.35
106.72
3.5
3.0
mg/l
1.4
1.7
17.20
774
2791
(3039000) Anion gap in Blood
798
3024
2.37
105.94
7.8
6.6
mmol/l
10.9
11.3
3.53
723
2732
(3018572) Chloride [Moles/volume] in Blood
798
3025
2.37
105.86
7.8
6.6
mmol/l
105.2
104.8
1.39
723
2733
(3004119) Hemoglobin [Mass/volume] in Venous blood
1770
8999
1.80
105.48
3.5
3.3
g/l
118.2
130.6
93.80
1739
8772
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
182
249
6.47
105.36
1.3
1.4
%
20.8
26.2
1.23
154
204
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
102
62
14.52
105.10
2.2
1.0
ug/l
10.0
3.0
0.84
73
28
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
1352
6330
1.94
104.27
3.8
4.2
mmol/l
24.3
24.2
0.37
1249
5600
(3020891) Body temperature
1263
5823
1.97
101.81
5.2
4.9
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
1410
6762
1.90
101.08
4.6
3.9
%
47.0
47.8
0.60
1403
6681
(3022806) Fractional oxyhemoglobin in Capillary blood
538
1726
2.79
100.47
1.9
1.8
%
89.2
89.5
0.47
531
1702
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
110
6
161.89
99.87
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
3817
45536
0.67
98.84
2.9
3.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
205
342
5.31
97.17
1.5
2.0
u/ml
20723.4
37199.6
0.23
25
55
(3000060) B lymphocytes [#/volume] in Blood
147
176
7.38
95.90
2.1
2.0
e6/l
253.1
146.4
0.39
62
112
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
139
158
7.77
94.71
1.4
1.4
%
11.9
9.6
0.43
84
72
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
106
83
11.27
94.47
2.0
4.3
mg/l
0.9
1.5
1.31
69
73
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
382
1063
3.20
91.56
1.2
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
498
1631
2.73
89.41
2.4
1.7
pg
32.2
32.6
0.84
490
1617
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
726
2843
2.29
89.25
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
726
2844
2.29
89.18
1.4
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
392
1139
3.06
87.41
2.9
2.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1597
22582
0.59
87.03
1.2
1.3
u/ml
20.5
14.3
1.09
579
8376
(3051651) Icteric interference index of Serum or Plasma
278
653
3.78
86.28
3.7
4.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
755
3057
2.22
85.66
2.7
3.2
kpa
8.0
8.0
0.08
694
2839
(3049717) Cytology report of Urine Cyto stain
1014
4600
1.99
85.27
2.7
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5177
35168
1.40
83.59
4.7
3.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
1354
6893
1.78
79.47
3.0
2.8
%
1.2
1.2
0.12
1344
6860
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
538
1942
2.47
79.31
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1776
23959
0.62
78.93
1.2
1.3
iu/ml
45.4
39.3
0.73
525
7490
(3022217) INR in Platelet poor plasma by Coagulation assay
3250
20483
1.47
78.48
18.1
27.6
inr
1.3
1.4
4.56
572
2776
(3026692) Albumin [Mass/volume] in Peritoneal fluid
173
301
5.08
78.36
1.1
1.6
g/l
15.7
12.7
3.66
150
215
(44786800) Granulocytes/100 leukocytes in Body fluid
115
132
7.69
77.77
1.3
1.3
%
21.8
27.6
0.77
92
95
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
1324
6739
1.78
77.70
3.0
2.8
%
0.7
0.7
3.61
1299
6446
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
700
2881
2.18
76.20
1.6
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
670
2717
2.21
75.66
1.2
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
94
86
9.64
75.56
1.5
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
167
291
5.07
75.53
3.2
2.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
5391
37369
1.37
75.33
4.9
4.2
estimate
0.0
0.0
0.38
2164
11502
(3032352) Blasts [#/volume] in Cerebral spinal fluid
80
58
12.16
74.73
1.8
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
4291
28678
1.40
74.72
4.0
3.9
ng/l
350.6
584.3
2.05
3533
23210
(3036489) Thrombin time
956
4461
1.93
73.89
2.0
1.9
s
21.9
21.7
0.58
893
3885
(3042010) Triglyceride [Moles/volume] in Pleural fluid
125
168
6.57
73.65
1.3
1.3
mmol/l
1.4
1.3
0.09
98
96
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
110
130
7.47
72.61
1.3
1.4
%
79.5
65.5
3.35
94
106
(40762365) Oxygen content in Arterial blood by calculation
130
185
6.21
72.57
4.3
2.6
ml/dl
14.1
15.2
3.45
124
169
(3025468) Yersinia sp identified in Specimen by Organism specific culture
462
1621
2.54
72.29
1.7
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
462
1623
2.54
72.11
1.7
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
462
1628
2.53
71.65
1.7
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
13375
127724
0.75
71.61
5.5
4.7
mu/l
2.6
2.1
1.18
12055
115847
(3024522) Salmonella sp identified in Specimen by Organism specific culture
465
1648
2.51
71.25
1.7
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
636
2594
2.19
70.79
2.7
2.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
4354
29417
1.39
70.39
1.7
1.7
mg/l
2.3
1.2
34.30
3636
22584
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
1232
6320
1.76
70.19
1.5
1.6
g/l
1.9
1.6
15.85
1024
5377
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
462
1646
2.50
70.02
1.7
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
471
1697
2.47
69.70
1.7
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
939
4441
1.90
69.63
4.2
4.5
mmol/l
3.9
3.9
0.13
864
4183
(3052851) Hemolysis interference index of Serum or Plasma
865
3992
1.94
69.01
3.8
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
2356
14300
1.51
67.62
1.3
1.3
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
102
120
7.50
67.60
4.1
1.2
ng/l
91.8
101.7
0.18
47
39
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
491
1841
2.38
66.60
1.2
1.3
u/ml
290.3
284.7
0.16
324
1181
(3025941) Bacteria identified in Stool by Culture
1328
7060
1.70
66.49
1.3
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
728
3208
2.03
66.20
1.7
1.3
iu/l
31.5
32.4
0.29
605
2777
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
191
416
4.06
65.84
1.8
1.1
ug/l
2.7
2.8
0.06
129
330
(3002331) Protein [Mass/volume] in Peritoneal fluid
146
256
5.04
65.62
1.2
1.6
g/l
30.0
47.5
0.34
127
195
(3022313) Gas panel - Capillary blood
1234
6485
1.72
64.39
4.0
3.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
791
3632
1.95
64.00
2.9
3.2
mmol/l
24.9
24.9
0.01
672
3204
(3008037) Lactate [Moles/volume] in Venous blood
751
3400
1.98
63.29
3.9
3.2
mmol/l
1.7
1.6
0.45
744
3327
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
441
1619
2.42
62.69
3.9
1.8
u/l
608.9
3931.0
5.28
165
595
(21494755) Public health laboratory ask at order entry panel
503
9203
0.47
62.67
1.2
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
525
9445
0.47
62.36
1.6
1.8
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
51
22
20.41
61.37
5.2
1.1
estimate
0.0
—
—
12
0
(1761482) Bacteria [#/volume] in Urine by Culture
837
3983
1.88
60.81
5.0
4.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
84
89
8.32
60.61
2.7
2.0
pmol/l
85.4
66.3
0.26
68
82
(3038515) Glucose [Moles/volume] in Venous blood
713
3238
1.97
59.53
4.0
3.3
mmol/l
7.5
7.7
0.86
707
3171
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
293
899
2.89
59.47
1.6
1.3
nmol/l
0.2
0.3
2.33
203
687
(3041918) Cholesterol [Moles/volume] in Pleural fluid
133
236
4.98
59.01
1.3
1.2
mmol/l
1.8
1.5
1.77
107
122
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
268
6119
0.38
57.95
1.4
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
10987
86194
1.27
55.93
4.3
3.0
u/l
98.8
48.0
126.72
10292
79069
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
276
848
2.88
55.90
1.5
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
475
1894
2.23
55.87
2.9
2.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
269
836
2.85
53.38
1.5
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
7045
52589
1.28
53.05
5.0
4.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
8947
68807
1.26
52.25
4.7
3.8
estimate
0.0
0.0
0.54
2366
11514
(3037756) Immunofixation for Serum or Plasma
606
2724
1.98
52.08
1.5
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
1046
5577
1.68
51.50
4.3
3.8
mmol/l
25.1
24.9
1.53
968
5096
(3012516) Albumin [Mass/volume] in Urine
4398
47297
0.76
50.55
3.1
3.3
mg/l
747.0
319.4
4.85
2859
29779
(3004588) Protein electrophoresis panel - Serum or Plasma
1653
9869
1.51
50.48
2.4
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
8831
67988
1.26
50.37
6.2
5.0
estimate
0.0
0.0
1.84
2404
11885
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
93
141
5.81
48.88
1.3
1.3
u/l
81.2
273.4
0.38
74
93
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
2106
13302
1.44
48.22
2.9
3.0
ng/l
194.5
221.7
1.88
1945
12166
(3016650) Hepatitis A virus Ab [Presence] in Serum
436
1785
2.17
48.09
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
274
911
2.66
47.90
2.5
2.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
560
2530
1.97
47.44
1.3
1.4
mmol/l
61.3
63.9
0.67
418
2018
(3035350) Ketones [Presence] in Urine by Test strip
8797
67985
1.25
47.37
4.6
3.7
estimate
0.0
0.0
0.80
2398
11643
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
75
94
7.03
47.14
1.3
2.8
%
52.9
58.3
0.43
54
57
(3009508) Creatinine [Moles/volume] in Urine
4580
48626
0.77
46.70
2.9
3.2
mmol/l
7.3
7.5
1.25
3664
40729
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
99
168
5.20
46.25
1.3
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
264
880
2.66
45.94
1.3
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
4733
49916
0.78
45.39
3.8
4.0
mg/mmol
12.2
8.5
5.14
3049
31485
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
462
1979
2.08
45.35
1.4
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1286
7437
1.55
45.30
4.6
3.0
pmol/l
4.3
4.4
4.05
1180
6507
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
208
617
2.98
44.94
1.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
208
617
2.98
44.94
1.6
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
2414
15804
1.39
44.82
1.5
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
157
393
3.53
44.62
1.3
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
135
306
3.89
44.24
2.5
1.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
98
172
5.02
44.12
1.7
1.5
—
—
—
0
0
(1002224) Polysomnography panel
222
4849
0.40
43.21
1.0
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
665
3281
1.81
42.97
2.3
2.2
g/l
120.3
131.1
20.25
501
2386
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
74
103
6.33
42.31
1.3
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
77
113
6.00
41.84
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
245
825
2.63
41.83
1.1
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
175
4180
0.36
41.68
1.6
1.7
mg/l
5.6
3.7
1.59
142
2946
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
229
762
2.66
40.05
2.0
1.8
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
396
1682
2.09
39.80
1.1
1.1
g/l
1.6
1.5
6.76
370
1499
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
177
518
3.02
39.21
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1122
14554
0.66
39.12
1.5
1.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
86
152
4.99
38.46
1.7
1.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
924
5150
1.60
38.03
2.2
2.3
ug/l
278.9
625.2
5.48
867
4841
(3013005) Retinol [Moles/volume] in Serum or Plasma
143
375
3.37
37.93
1.3
1.6
umol/l
1.9
2.0
0.33
133
351
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
565
2758
1.82
37.82
1.4
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
207
674
2.72
37.79
2.1
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
418
1850
2.01
37.59
1.1
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
76
124
5.40
37.10
1.1
1.1
u/l
22.8
18.3
0.87
59
74
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2497
28018
0.75
36.92
1.2
1.3
u/ml
1.5
1.7
0.26
638
7370
(40760888) Immunoglobulin light chains.free panel - Serum
639
3265
1.74
36.65
3.2
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
5140
38211
1.25
36.52
4.0
2.4
umol/l
2884.4
5275.4
4.30
4603
32540
(3008295) Osmolality of Serum or Plasma
313
1257
2.21
36.30
1.2
1.4
mosm/kgh2o
276.7
277.1
0.11
262
942
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
787
4315
1.63
34.62
3.3
1.6
ratio
5.3
2.1
0.73
57
348
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
144
402
3.16
34.60
3.5
2.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1727
11169
1.39
33.95
5.3
2.4
ml/min/173m2
64.0
63.3
0.34
763
4361
(3001964) Herpes simplex virus Ag [Presence] in Specimen
123
315
3.44
33.89
1.3
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
95
203
4.12
33.79
2.2
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
801
4447
1.61
33.49
3.4
1.6
mg/l
51.8
36.6
0.49
644
3577
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
320
1340
2.12
33.44
1.4
1.2
u/l
104.7
57.4
2.08
219
864
(3001122) Ferritin [Mass/volume] in Serum or Plasma
7049
54549
1.21
33.13
2.6
2.8
ug/l
322.8
131.1
81.87
6541
49871
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
63
96
5.78
33.03
1.3
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
801
4462
1.60
33.02
3.3
1.6
mg/l
51.8
46.9
0.65
647
3594
(3051611) Lipemic interference index of Serum or Plasma
326
1396
2.07
32.14
3.6
3.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
258
1008
2.26
32.03
2.1
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
169
543
2.75
31.73
1.4
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
169
543
2.75
31.73
1.4
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
289
1191
2.15
31.50
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
101
242
3.68
30.75
1.2
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
216
796
2.40
30.67
1.7
1.5
u/l
5.5
6.1
0.20
114
353
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
55
80
6.05
30.21
1.3
2.8
%
24.0
13.4
1.03
31
40
(3004451) EKG impression Narrative
197
704
2.47
29.91
1.2
1.3
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
46
56
7.23
29.71
6.8
1.1
pmol/l
1072.6
1.5
0.65
27
12
(3015736) pH of Urine
6832
53129
1.20
29.42
4.2
3.6
ph
5.9
5.4
2.47
23
19
(3019550) Sodium [Moles/volume] in Serum or Plasma
17094
144759
1.29
29.39
36.7
15.9
mmol/l
138.6
139.8
307.65
16809
140713
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
11203
105550
0.84
29.04
4.9
3.9
pmol/l
15.1
14.9
13.71
10159
94943
(3022475) Manganese [Moles/volume] in Blood
42
48
7.70
28.59
1.3
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
13443
111145
1.20
28.19
43.0
15.8
%
14.8
13.7
307.65
13300
108381
(3017732) Neutrophils [#/volume] in Blood
1414
9142
1.39
27.66
4.8
2.9
e9/l
4.2
4.1
0.98
1119
6709
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
98
250
3.45
27.26
6.2
1.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
60
105
5.03
27.22
1.7
3.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
60
105
5.03
27.22
3.4
6.3
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
179
643
2.46
26.93
1.2
1.1
u/l
122.5
83.8
2.51
153
495
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
177
644
2.43
25.93
1.2
1.1
u/l
59.3
21.6
3.32
145
473
(3023103) Potassium [Moles/volume] in Serum or Plasma
17096
145149
1.27
25.83
36.9
16.0
mmol/l
4.0
4.0
0.88
16795
140858
(3007566) Smooth muscle Ab [Titer] in Serum
631
3537
1.59
25.36
1.2
1.2
titre
90.8
138.4
1.30
60
301
(3044889) 12 lead EKG panel
12061
99308
1.17
24.23
4.6
4.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
808
10182
0.68
23.78
1.1
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
179
682
2.32
23.71
2.0
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
312
4894
0.55
23.67
1.7
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
367
1817
1.79
23.59
1.8
2.5
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
23
14
14.44
23.51
1.0
1.1
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
23
14
14.44
23.51
1.0
1.1
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
23
14
14.44
23.51
1.0
1.1
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
23
14
14.44
23.51
1.0
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
24
16
13.19
23.40
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
215
3736
0.50
22.81
1.0
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
65
141
4.06
22.80
1.3
2.5
—
—
—
0
0
(3019977) pH of Arterial blood
198
803
2.18
22.62
2.7
2.4
ph
7.4
7.4
0.40
72
278
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
487
6737
0.63
22.55
1.5
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
102
302
2.98
22.36
1.5
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
558
7477
0.65
22.35
1.5
1.8
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
34
41
7.29
22.15
1.3
1.5
ng/l
160.7
199.9
2.35
28
36
(3034770) Mitochondria Ab [Titer] in Serum
614
3538
1.54
21.90
1.2
1.2
titre
375.6
1082.0
—
9
118
(3052592) Norovirus Ag [Presence] in Stool
91
256
3.13
21.77
1.5
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1702
18827
0.77
21.36
3.7
4.9
%
31.4
32.6
4.35
1140
12686
(21494434) Karyotype in Bone marrow
222
963
2.04
21.32
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
6548
51803
1.17
20.84
8.4
3.8
ug/l
15.3
2.3
17.23
5828
46519
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
165
650
2.24
20.29
1.1
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
12366
114294
0.86
19.80
45.0
17.4
g/l
329.6
332.3
196.45
12252
113356
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
53
110
4.24
19.73
1.1
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
2619
19192
1.23
19.56
1.3
1.2
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
42
75
4.93
18.71
1.2
1.0
u/field
1.2
1.1
0.42
36
42
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
49
101
4.27
18.42
1.0
1.1
iu/ml
16.7
15.0
0.06
23
31
(4094501)
282
4222
0.58
18.09
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
524
3046
1.52
18.02
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1524
16680
0.79
17.31
1.4
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
463
2657
1.54
16.92
1.6
1.8
mu/l
312.6
297.3
0.57
445
2408
(3040151) Glucose [Moles/volume] in Capillary blood
318
1665
1.69
16.92
6.3
11.8
mmol/l
7.1
7.6
1.81
278
1358
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
23
7
28.88
16.79
1.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
798
9492
0.73
16.65
1.2
1.3
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
32
51
5.52
16.13
1.0
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1718
18362
0.80
15.74
1.3
1.3
titre
481.5
556.3
1.10
369
4046
(3010370) Gastrin [Moles/volume] in Serum or Plasma
55
141
3.43
15.36
2.1
1.5
pmol/l
51.2
55.1
0.09
47
118
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
239
3570
0.58
15.26
1.7
1.7
nmol/l
45.1
43.5
0.32
232
3437
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
502
3006
1.48
15.03
1.4
1.8
iu/l
3.4
7.3
0.73
122
1056
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
789
9253
0.74
14.99
2.3
2.4
au/ml
18.2
29.3
0.89
21
406
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
94
1869
0.44
14.74
1.1
1.1
u/ml
1.4
1.3
0.04
30
723
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
68
204
2.93
14.73
1.1
1.1
pmol/l
4.3
3.8
0.08
15
24
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
706
8396
0.73
14.70
1.2
1.3
au/ml
56.3
51.4
0.12
22
358
(40763480) Human metapneumovirus Ag [Presence] in Specimen
25
34
6.46
14.69
1.5
1.0
—
—
—
0
0
(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method
28
44
5.59
14.33
1.3
1.1
u/field
0.9
0.8
0.28
22
24
(3000330) Specific gravity of Urine by Test strip
1108
7615
1.29
14.22
5.4
3.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
148
645
2.02
14.22
2.0
1.9
ml
1771.6
1968.4
1.50
134
560
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
836
5537
1.34
13.99
2.6
1.4
g/l
3.7
3.9
1.76
591
3914
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
837
5548
1.34
13.93
2.6
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
837
5553
1.34
13.85
2.6
1.4
g/l
7.8
7.5
4.50
601
4064
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
407
5264
0.67
13.75
1.1
1.1
u/ml
1.0
8.9
—
5
80
(3008401) Mugwort IgE Ab [Units/volume] in Serum
79
1616
0.43
13.37
1.1
1.1
u/ml
0.6
1.0
0.52
26
628
(3010726) Horse dander IgE Ab [Units/volume] in Serum
65
1433
0.40
13.21
1.0
1.1
u/ml
0.2
1.5
—
9
324
(3003888) Timothy IgE Ab [Units/volume] in Serum
84
1668
0.44
13.18
1.0
1.1
u/ml
6.2
3.4
0.46
35
788
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
161
743
1.91
13.17
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
77
263
2.58
13.12
1.3
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
241
3455
0.61
13.12
1.6
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
784
5194
1.34
13.11
2.6
1.4
g/l
9.5
10.2
3.92
654
4303
(3036603) Volume of Urine
172
813
1.87
13.08
1.7
1.4
ml
1874.8
1957.5
0.33
79
198
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
161
747
1.90
12.97
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
181
2775
0.57
12.82
1.4
1.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
71
236
2.65
12.78
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
170
809
1.85
12.67
1.1
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
159
741
1.89
12.65
1.8
1.9
u/field
2.1
2.8
0.56
124
494
(3032057) Clostridioides difficile [Presence] in Stool
86
316
2.40
12.60
1.8
1.6
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
36
1025
0.31
12.58
1.0
1.0
u/ml
0.2
0.3
—
5
242
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
633
4090
1.37
12.47
2.5
1.5
g/l
0.0
0.0
0.76
574
3698
(3014133) Dog dander IgE Ab [Units/volume] in Serum
53
1238
0.37
12.33
1.0
1.1
u/ml
0.5
3.2
8.00
13
483
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
124
535
2.04
12.31
2.4
2.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
585
3751
1.38
12.09
1.2
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
225
1179
1.68
12.09
2.1
2.1
u/field
2.5
2.2
0.37
106
431
(3000012) Reticulocyte production index
158
748
1.86
12.00
1.6
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1884
13991
1.20
11.99
2.3
2.4
ug/l
5.7
7.8
4.08
1629
12161
(3014765) Yersinia sp identified in Stool by Organism specific culture
588
3784
1.38
11.89
1.2
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
773
5189
1.32
11.84
2.7
1.4
g/l
3.4
3.1
14.19
602
3999
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
15
14
9.42
11.81
4.6
3.8
mg/l
4.3
4.9
—
15
7
(42529406) Shigella sp [Presence] in Stool by Culture
587
3797
1.37
11.51
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
7966
74431
0.90
11.49
2.7
2.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
6578
62101
0.89
11.49
1.9
2.0
pmol/l
88.9
95.6
26.67
3972
31543
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
564
3633
1.37
11.36
1.7
2.0
mg/l
10.8
11.2
0.53
528
3362
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
211
3012
0.61
11.34
1.3
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
242
1317
1.62
11.26
2.1
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
693
4616
1.33
11.22
2.7
1.5
g/l
0.9
0.5
2.36
597
3896
(3017569) Oxygen content in Arterial blood
146
690
1.86
11.19
2.4
2.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
30
63
4.19
11.11
1.1
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
148
2299
0.56
11.06
1.3
1.3
—
—
—
0
0
(4010399)
996
10887
0.79
11.06
1.3
1.5
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
29
60
4.25
10.95
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
177
2614
0.59
10.94
1.7
2.0
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
11
0
+∞
10.90
1.0
0.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
27
53
4.48
10.87
1.0
1.1
%
8.0
9.0
0.99
22
46
(3027008) Opiates [Presence] in Urine
177
2608
0.59
10.85
1.5
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
172
2551
0.59
10.82
1.6
1.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1464
10722
1.22
10.76
3.1
3.9
ng/l
91.9
93.2
0.18
1252
9061
(3023430) Cat dander IgE Ab [Units/volume] in Serum
52
1150
0.40
10.75
1.0
1.1
u/ml
1.4
3.3
2.12
13
443
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
575
3752
1.36
10.70
2.6
1.5
g/l
0.0
0.0
0.00
525
3419
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
583
3813
1.35
10.69
2.6
1.5
g/l
0.0
0.0
0.50
526
3431
(3000764) Benzodiazepines [Presence] in Urine
177
2597
0.59
10.68
1.5
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
533
6285
0.74
10.55
1.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
140
667
1.85
10.49
1.1
1.1
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
31
70
3.89
10.47
1.7
1.2
u/l
988.6
194.3
0.41
24
60
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
104
448
2.04
10.45
2.7
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
104
448
2.04
10.45
2.7
2.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
154
757
1.79
10.44
1.6
1.2
u/l
51.5
22.2
3.85
135
636
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
25
48
4.58
10.34
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
229
1264
1.60
10.11
1.3
1.6
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
157
784
1.76
10.11
1.6
1.2
u/l
120.7
86.1
2.56
143
675
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
58
197
2.59
10.10
1.3
1.2
ng/l
91.3
122.6
0.50
35
135
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
826
5725
1.28
9.99
1.7
1.9
u/l
39.7
39.0
0.46
729
4988
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
725
8131
0.77
9.98
1.3
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
105
463
2.00
9.92
1.7
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
1463
15197
0.83
9.85
2.0
2.2
ug/g
212.2
138.0
6.57
1179
11757
(40761535) Cells panel - Urine sediment
1653
12355
1.19
9.76
3.9
3.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
40
113
3.11
9.72
1.1
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
386
2399
1.42
9.67
1.3
1.3
miu/ml
140.3
211.8
3.65
100
1010
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
62
1216
0.45
9.57
1.0
1.0
ng/l
845.4
721.2
1.30
41
798
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
22
41
4.72
9.42
1.4
2.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
63
1220
0.45
9.41
1.0
1.0
ng/l
38.7
45.0
0.69
44
819
(3016879) Cocaine [Presence] in Urine
168
2413
0.61
9.35
1.6
2.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
70
270
2.28
9.32
2.0
2.7
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
33
85
3.41
9.28
1.2
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
63
1210
0.46
9.21
1.0
1.0
ng/l
364.5
332.5
0.25
46
828
(3051387) C reactive protein [Mass/volume] in Capillary blood
492
3215
1.35
9.14
3.7
3.5
mg/l
35.2
26.2
4.89
350
2095
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
4041
32355
1.12
9.09
1.7
1.7
pmol/l
25896267.8
31971958.8
0.28
3321
26411
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
43
132
2.86
9.09
1.4
1.1
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
19
32
5.22
9.09
1.9
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
43
133
2.84
8.98
1.4
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
43
133
2.84
8.98
1.4
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
12261
103810
1.10
8.93
4.3
4.2
mm/h
20.2
12.3
270.39
11239
95460
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
13
6
19.04
8.70
1.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
186
2559
0.63
8.63
1.8
1.9
pmol/l
186.4
197.4
0.73
173
2398
(3014271) Vancomycin [Susceptibility]
157
822
1.68
8.62
2.8
3.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
3663
29246
1.12
8.60
1.8
1.8
nmol/l
1240.7
1161.8
4.72
2860
21937
(3039443) Prostate specific Ag panel - Serum or Plasma
187
2566
0.64
8.58
1.6
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
135
679
1.75
8.56
3.2
3.9
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
19
34
4.91
8.52
1.1
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
5671
46373
1.10
8.52
2.3
2.2
u/l
183.3
222.7
2.69
5344
43195
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
75
311
2.12
8.42
1.6
1.1
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
147
764
1.69
8.31
1.2
1.2
u/l
301.9
375.8
0.50
139
708
(3044290) Cell count panel - Cerebral spinal fluid
404
2603
1.37
8.25
1.5
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
136
1991
0.60
8.25
1.6
2.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
18
32
4.94
8.14
1.7
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
160
867
1.63
7.74
1.3
1.5
umol/l
13.1
13.3
0.11
153
816
(3000475) Leukocytes [#/volume] in Synovial fluid
335
4033
0.72
7.70
1.7
1.6
e6/l
13928.5
13947.3
0.00
260
2927
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
40
130
2.71
7.67
3.0
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
313
1962
1.41
7.58
1.3
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
720
7816
0.80
7.57
1.3
1.3
u/ml
280.2
232.0
0.46
639
7235
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
624
4331
1.27
7.56
2.5
1.4
g/l
35.8
37.6
8.66
551
3644
(3020961) Endomysium IgA Ab [Titer] in Serum
505
5707
0.77
7.46
1.1
1.1
titre
275.8
228.6
0.17
12
132
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
317
3824
0.72
7.39
1.3
1.3
u/ml
34.1
41.3
0.22
22
231
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
365
4308
0.74
7.39
1.7
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
477
5421
0.77
7.37
1.2
1.2
u/ml
2.3
0.7
0.73
38
493
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
378
4432
0.74
7.32
1.4
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
225
1337
1.48
7.26
1.5
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
270
1666
1.43
7.17
1.6
1.2
nmol/l
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
172
970
1.56
7.09
1.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
172
970
1.56
7.09
1.3
1.3
mmol/l
2.7
2.2
2.76
166
903
(3048879) Bone marrow aspiration report
70
309
1.99
6.75
1.9
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
104
523
1.75
6.71
1.2
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
108
550
1.73
6.67
1.3
1.4
umol/l
42.7
22.2
5.63
103
516
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
17007
146987
1.12
6.65
26.6
9.3
u/l
27.2
26.0
11.09
16699
140524
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
281
3383
0.73
6.53
1.1
1.1
u/ml
4.5
8.7
1.69
25
332
(3009466) Valproate [Moles/volume] in Serum or Plasma
154
2064
0.65
6.45
4.1
4.7
umol/l
334.6
361.8
1.68
135
1744
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
167
958
1.54
6.43
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1424
14314
0.86
6.39
1.6
1.7
%
1.6
1.5
3.19
1194
12289
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
223
1360
1.44
6.36
3.3
3.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
5021
41282
1.09
6.36
5.9
3.7
%
21.7
24.0
19.96
2926
19706
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
298
3535
0.74
6.31
1.3
1.3
u/ml
6.4
6.8
0.06
58
587
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
17
36
4.15
6.30
1.2
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
440
2998
1.30
6.24
2.4
3.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
125
1731
0.63
6.12
1.1
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
296
3490
0.74
6.03
1.3
1.3
u/ml
7.4
6.2
0.09
44
379
(40761511) CBC panel - Blood by Automated count
16448
142051
1.11
5.94
30.9
12.8
—
—
—
0
0
(3046914) Granular casts [#/area] in Urine by Computer assisted method
13
23
4.97
5.91
1.6
1.1
u/field
0.8
0.6
—
8
13
(3044416) Complement C4 [Mass/volume] in Pleural fluid
24
68
3.10
5.91
1.1
1.2
g/l
0.1
0.1
0.91
18
46
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
291
1889
1.36
5.82
1.6
1.2
nmol/l
1.3
2.0
0.30
279
1813
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
21
520
0.35
5.81
1.2
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
270
1737
1.37
5.72
1.6
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
53
226
2.06
5.67
2.6
1.8
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
76
1159
0.57
5.56
1.7
2.0
ug/l
2.9
3.9
1.37
63
1025
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
38
718
0.46
5.51
1.3
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
124
691
1.58
5.49
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
331
2216
1.32
5.41
1.2
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
114
1549
0.64
5.19
1.3
1.5
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
75
1124
0.58
5.17
1.8
2.1
ug/l
1.9
2.4
1.39
63
935
(3011288) Drugs identified in Urine by Screen method
129
1706
0.66
5.16
1.9
2.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
15103
130137
1.08
5.12
36.4
12.1
ml/min/173m2
79.0
77.3
19.79
13853
104915
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
227
2711
0.73
5.11
1.3
1.2
u/ml
41.1
47.8
0.29
35
278
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
22
65
2.97
5.09
1.1
1.0
u/l
1.9
2.2
—
8
9
(3021788) Differential panel - Synovial fluid
254
2976
0.75
5.04
1.5
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
210
2532
0.73
5.03
1.4
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
23
509
0.40
5.02
1.7
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
414
2884
1.27
5.02
1.5
1.4
e6/l
34.2
25.2
0.25
324
2267
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
286
1898
1.33
5.01
1.6
1.2
nmol/l
0.4
0.3
0.36
31
139
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
64
990
0.57
4.99
1.2
1.3
pmol/l
47.9
102.6
1.00
39
297
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
48
208
2.03
4.97
1.4
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
414
2888
1.26
4.96
1.6
1.4
e6/l
582.1
1569.9
2.37
339
2389
(44813793)
58
919
0.55
4.93
1.0
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
161
973
1.46
4.93
1.1
1.2
mmol/l
35.0
34.0
0.25
140
805
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
45
768
0.51
4.89
1.1
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
153
917
1.47
4.89
1.7
2.2
min
495.0
500.7
0.28
96
696
(4062490)
209
1327
1.39
4.87
1.3
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
209
1329
1.39
4.83
1.3
1.4
g/l
2.7
3.0
1.31
135
930
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
14
383
0.32
4.82
1.5
2.0
mg/l
7.6
9.1
—
8
308
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
70
348
1.77
4.82
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
456
4936
0.81
4.81
1.7
1.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
313
2120
1.30
4.76
1.4
1.6
g/l
0.9
0.8
0.18
225
1598
(3016244) Insulin [Units/volume] in Serum or Plasma
103
571
1.59
4.73
1.9
3.2
mu/l
17.7
26.6
2.10
94
534
(3024139) IgG subclass 3 [Mass/volume] in Serum
208
1328
1.38
4.70
1.3
1.4
g/l
0.4
0.4
0.05
135
932
(3027135) IgG subclass 1 [Mass/volume] in Serum
208
1329
1.38
4.68
1.3
1.4
g/l
6.7
6.9
0.24
135
929
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
57
269
1.86
4.65
1.2
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
120
693
1.52
4.61
1.2
1.1
iu/ml
3.6
4.1
—
5
50
(3004616) Nuclear Ab [Presence] in Serum
142
1799
0.69
4.60
1.3
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
63
954
0.58
4.57
1.3
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
312
3505
0.78
4.56
1.4
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
257
2954
0.76
4.49
1.3
1.2
u/ml
2.6
6.1
1.10
26
232
(3016135) IgD [Mass/volume] in Serum
10
18
4.88
4.46
1.1
1.1
mg/l
19.4
109.7
—
10
18
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
461
3299
1.23
4.45
1.5
1.3
mg/l
603.2
545.9
1.02
442
3122
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
19
57
2.93
4.32
1.0
1.0
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
26
93
2.46
4.26
1.6
1.4
ml/s/173m2
1.8
0.9
2.01
13
58
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
19
58
2.88
4.20
1.2
1.4
u/field
0.9
1.1
—
9
36
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
342
3758
0.80
4.19
1.7
1.7
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
98
555
1.55
4.16
2.5
5.3
mg/l
2633.4
909.2
0.29
72
382
(3020564) Creatinine [Moles/volume] in Serum or Plasma
16940
146966
1.09
4.06
44.3
15.3
umol/l
80.4
79.5
2.21
16933
146898
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
212
1397
1.34
3.99
1.1
1.1
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
10
20
4.39
3.98
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
200
1309
1.35
3.94
1.8
2.3
ml
677.0
662.3
0.16
116
900
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
40
653
0.54
3.86
1.8
1.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
66
942
0.61
3.86
1.3
1.3
u/ml
2.0
1.2
0.21
32
487
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
441
3197
1.22
3.82
1.2
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
188
1227
1.35
3.79
1.7
1.5
—
—
—
0
0
(4034850)
488
5114
0.83
3.79
13.5
10.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
625
6411
0.85
3.77
2.1
1.8
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
19
62
2.69
3.75
2.1
5.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
347
2459
1.24
3.74
2.7
3.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
151
954
1.39
3.73
1.6
1.6
umol/l
57.8
70.9
—
6
60
(3014051) Protein [Presence] in Urine by Test strip
298
3274
0.80
3.70
2.4
2.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
401
2891
1.22
3.68
1.4
1.2
mmol/l
3.7
3.9
2.11
371
2719
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
16
48
2.93
3.66
1.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
19
63
2.65
3.65
1.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
278
0.32
3.64
1.0
1.0
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
91
526
1.52
3.58
1.6
1.7
nmol/l
13.5
8.6
0.32
79
434
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
57
823
0.61
3.53
1.3
1.4
u/l
10.9
5.8
0.98
46
698
(3045683) HLA typing for celiac disease panel - Blood or Tissue
108
649
1.46
3.53
1.0
1.0
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
74
410
1.59
3.51
1.4
1.2
%
16.4
20.9
0.26
17
56
(4024509)
118
1464
0.71
3.50
1.6
1.6
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
98
579
1.49
3.49
4.8
6.4
mmol/l
24.5
25.3
0.66
88
525
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
12
31
3.40
3.46
1.0
1.9
umol/l
141.2
253.0
0.78
12
25
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
15
45
2.93
3.44
1.2
1.0
nmol/l
247.9
293.9
0.46
15
45
(3038026) Centromere Ab [Units/volume] in Serum
95
1220
0.68
3.43
1.3
1.2
u/ml
13.0
51.7
—
6
56
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
17
55
2.72
3.42
1.7
1.4
mg/l
0.3
0.8
—
7
38
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
17
55
2.72
3.42
1.7
1.4
mg/l
1.4
2.2
—
6
33
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
17
55
2.72
3.42
1.7
1.4
mg/l
0.8
2.8
—
6
33
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
17
55
2.72
3.42
1.7
1.4
mg/l
0.8
0.7
—
7
38
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
17
55
2.72
3.42
1.7
1.4
mg/l
0.3
1.7
—
7
38
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
17
55
2.72
3.42
1.7
1.4
mg/l
0.5
2.9
—
9
37
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
17
55
2.72
3.42
1.7
1.4
mg/l
0.4
2.4
—
8
38
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
17
55
2.72
3.42
1.7
1.4
mg/l
0.7
1.8
—
9
41
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
17
55
2.72
3.42
1.7
1.4
mg/l
1.4
3.7
—
6
36
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
122
1497
0.71
3.40
1.0
1.1
u/ml
2.4
3.9
1.13
34
598
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
3484
28869
1.07
3.40
3.5
2.7
ug/l
1.2
0.7
22.59
2559
19519
(3010375) cycloSPORINE [Mass/volume] in Blood
88
512
1.51
3.38
32.1
28.2
ug/l
115.9
116.8
0.05
74
421
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
93
1194
0.68
3.36
1.2
1.2
u/ml
51.6
47.7
—
9
89
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
50
253
1.74
3.36
1.4
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
67
368
1.60
3.32
1.0
1.0
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
93
1190
0.68
3.30
1.2
1.2
u/ml
76.8
88.0
—
8
51
(3028707) Methadone [Presence] in Urine by Screen method
93
1189
0.69
3.29
1.8
2.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
113
697
1.43
3.25
1.3
1.7
—
—
—
0
0
(3000492) Spirometry study
1274
12338
0.90
3.23
1.4
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
728
5593
1.15
3.22
1.3
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
31
136
2.00
3.22
1.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
22
407
0.47
3.18
1.7
1.6
ug/l
12.1
9.0
1.24
22
407
(3046861) Legionella sp Ag [Presence] in Urine
19
68
2.46
3.17
1.1
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
63
862
0.64
3.14
1.3
1.5
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
27
114
2.08
3.11
1.9
1.3
nmol/l
0.1
0.3
1.32
21
78
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
151
1764
0.75
3.10
1.1
1.1
—
—
—
0
0
(3036005) Urine sediment comments by Light microscopy Narrative
7
10
6.15
3.05
1.0
1.1
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
17
59
2.53
3.02
1.7
1.5
mg/l
1.7
1.4
—
7
38
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
8
14
5.02
2.99
1.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
15
49
2.69
2.99
1.0
1.0
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
14
44
2.80
2.99
7.0
4.0
%
22.7
20.5
—
6
22
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
184
0.33
2.94
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
971
7660
1.12
2.87
1.2
1.2
iu/ml
114.9
136.9
0.91
257
2915
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
98
605
1.42
2.86
1.3
1.2
%
76.5
57.7
1.30
13
54
(3024932) HLA-DR beta [Type]
64
362
1.55
2.85
1.4
1.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
18
67
2.36
2.79
1.4
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
130
846
1.35
2.78
2.6
2.1
umol/l
71.4
16.7
1.17
18
80
(42529582) MDA5 Ab [Presence] in Serum by Line blot
22
386
0.50
2.78
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
22
386
0.50
2.78
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
22
386
0.50
2.78
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
22
386
0.50
2.78
1.1
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
87
1082
0.70
2.71
1.3
1.1
—
38.3
—
0
12
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
36
541
0.58
2.71
2.5
3.0
umol/l
27.1
28.5
0.36
29
410
(3020874) Milk IgE Ab [Units/volume] in Serum
38
562
0.59
2.69
1.0
1.0
u/ml
0.4
1.7
1.11
11
165
(4306422)
153
1744
0.77
2.68
1.2
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
85
1058
0.70
2.67
1.8
1.7
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
14
47
2.62
2.67
1.4
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
178
0.35
2.67
1.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
29
458
0.56
2.62
1.6
1.5
—
—
—
0
0
(4146454)
167
1876
0.78
2.62
2.4
2.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
64
836
0.67
2.62
1.4
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
63
364
1.52
2.59
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
255
1830
1.23
2.58
2.1
1.3
mu/l
71.9
60.4
0.33
224
1625
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
323
2374
1.20
2.56
1.3
1.5
—
—
—
0
0
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
13
43
2.66
2.55
1.2
1.0
mg/l
0.0
0.0
0.35
13
37
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
5
6
7.32
2.52
1.4
1.3
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
17
65
2.30
2.51
2.1
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
4143
34846
1.06
2.47
1.6
1.5
nmol/l
19.0
20.4
7.65
3733
29385
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
59
341
1.52
2.44
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
59
343
1.51
2.38
1.0
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
58
336
1.52
2.38
1.1
1.1
%
82.9
88.0
0.43
29
167
(3014599) Egg white IgE Ab [Units/volume] in Serum
38
543
0.61
2.38
1.0
1.0
u/ml
0.4
1.0
—
7
133
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
142
1605
0.78
2.38
1.2
1.2
mmol/l
7.8
7.6
0.37
102
1134
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
198
1397
1.25
2.37
1.3
1.3
—
36.4
—
0
13
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
30
147
1.79
2.33
1.0
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
17216
152337
0.94
2.28
51.6
19.6
g/l
123.6
136.3
307.65
16968
149496
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
60
355
1.49
2.25
1.1
1.1
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
8
20
3.51
2.25
1.0
1.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
56
327
1.51
2.24
1.1
1.1
%
75.7
88.7
1.37
27
167
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
9
25
3.16
2.23
1.0
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
152
1686
0.79
2.21
1.1
1.1
%
118.5
117.6
0.10
135
1512
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
93
1.98
2.21
1.1
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
17216
152313
0.94
2.20
51.3
19.4
e12/l
4.1
4.5
307.65
16808
146738
(3010813) Leukocytes [#/volume] in Blood
17218
152327
0.94
2.19
51.4
19.5
e9/l
7.0
6.7
28.86
16815
146771
(3041184) Isoniazid [Presence] in Urine
7
16
3.84
2.19
1.7
2.9
—
—
—
0
0
(3024731) MCV [Entitic volume]
17216
152305
0.94
2.17
51.2
19.4
fl
91.9
91.3
34.30
16965
149447
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
62
782
0.70
2.17
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
62
782
0.70
2.17
1.2
1.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
57
337
1.49
2.16
1.1
1.1
%
103.1
106.7
0.28
52
304
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
62
781
0.70
2.16
1.2
1.4
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
8
21
3.35
2.15
2.9
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
103
1195
0.76
2.14
1.6
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
62
779
0.70
2.13
1.2
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
57
339
1.48
2.11
1.0
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
17216
152283
0.94
2.10
51.1
19.3
pg
30.3
30.4
11.72
16966
149434
(3045716) Anion gap in Serum or Plasma
108
718
1.32
2.10
2.0
2.3
mmol/l
9.2
9.0
0.20
79
520
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
7
17
3.62
2.08
1.0
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
14
54
2.28
2.06
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
422
4234
0.87
2.06
1.6
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
207
0.42
2.06
1.9
2.0
umol/l
19.6
17.8
—
10
207
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
194
2076
0.82
2.05
1.6
1.5
%
66.9
59.0
2.47
123
1316
(40768443) Skin Pathology biopsy report
707
5599
1.11
2.05
1.2
1.2
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
13
4.05
2.02
2.0
5.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
804
6416
1.10
2.02
1.4
1.5
u/ml
15.5
15.1
0.02
14
157
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
22
103
1.88
2.00
1.2
1.3
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
5
9
4.88
1.99
1.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
67
818
0.72
1.97
1.1
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
17216
152230
0.94
1.94
51.4
19.4
e9/l
249.5
246.6
5.29
16854
147272
(44806071)
8
165
0.43
1.94
1.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
22
340
0.57
1.93
1.5
1.6
ng/l
146.0
119.3
0.52
22
340
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
100
667
1.32
1.93
2.3
2.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
113
1272
0.78
1.91
1.1
1.2
%
92.6
95.6
0.62
104
1190
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
83
974
0.75
1.91
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
83
973
0.75
1.90
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
83
972
0.75
1.88
1.1
1.2
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
7
19
3.24
1.88
1.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1939
18011
0.94
1.87
1.3
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
22
106
1.82
1.85
2.5
2.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
83
969
0.75
1.85
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
83
969
0.75
1.85
1.1
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
56
342
1.44
1.85
1.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
111
1244
0.78
1.82
1.2
1.6
u/ml
41.7
25.8
1.49
20
277
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
196
0.45
1.82
1.6
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
83
966
0.75
1.82
1.1
1.2
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
28
398
0.62
1.80
1.1
1.3
nmol/l
93.9
136.1
1.85
23
276
(3017704) Immunofixation for Urine
111
761
1.28
1.78
1.5
1.2
—
—
—
0
0
(44806420)
76
495
1.35
1.75
2.3
2.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
29
155
1.64
1.74
1.1
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
93
1057
0.77
1.73
1.1
1.3
titre
991.4
409.5
—
7
96
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
48
289
1.46
1.72
1.0
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
183
1333
1.21
1.72
1.3
1.3
nmol/l
1.3
1.4
0.59
167
1207
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
33
183
1.58
1.72
2.5
2.8
u/field
0.8
0.5
0.56
33
183
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
250
1873
1.17
1.71
2.2
2.1
mg/l
37.4
26.3
1.55
68
495
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
28
149
1.65
1.71
1.1
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
14
59
2.08
1.71
1.8
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
55
674
0.72
1.70
1.3
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
39
508
0.67
1.69
1.2
1.4
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
44
0.00
1.69
0.0
1.0
—
3.8
—
0
34
(3007164) IgA [Mass/volume] in Serum or Plasma
2808
23619
1.05
1.68
1.7
1.3
g/l
2.4
2.6
5.54
1936
13541
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
385
2983
1.14
1.67
1.2
1.3
titre
92.0
130.3
—
5
60
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
52
640
0.71
1.66
14.3
16.6
nmol/l
1814.2
1420.1
1.44
46
614
(4268621)
107
1188
0.79
1.66
2.2
2.3
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
12
48
2.20
1.65
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
278
2108
1.16
1.65
1.6
1.6
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
53
329
1.42
1.64
2.4
2.6
mmol/l
6.6
7.8
2.01
31
202
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
41
242
1.49
1.64
1.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
165
0.48
1.62
1.0
1.1
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
6
17
3.10
1.60
1.0
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
163
1722
0.83
1.59
1.3
1.3
u/ml
43.7
55.3
0.23
13
122
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
75
496
1.33
1.59
1.2
1.7
%
191.9
154.1
2.56
66
460
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
166
1749
0.83
1.58
1.2
1.2
u/ml
2.8
4.0
1.99
63
787
(3042733) HLA Ab [Presence] in Serum
32
426
0.66
1.57
3.7
5.2
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
10
38
2.31
1.54
1.0
1.1
—
—
—
0
0
(4038314)
7
23
2.67
1.54
1.0
1.3
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
7
23
2.67
1.54
4.0
3.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
127
0.41
1.52
1.2
1.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
12
50
2.11
1.52
1.1
1.1
—
—
—
0
0
(4198724)
25
348
0.63
1.51
1.4
2.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
79
532
1.31
1.50
1.1
1.1
ng/l
1312.5
737.0
0.21
19
127
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
32
183
1.54
1.49
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
27
368
0.64
1.49
1.3
1.6
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
38
226
1.48
1.49
1.1
1.2
%
78.3
84.5
0.31
12
79
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
7
24
2.56
1.47
4.0
3.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
50
315
1.39
1.45
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
52
622
0.73
1.44
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
13954
121302
1.04
1.43
33.5
14.6
%
36.3
39.6
212.34
8649
81310
(3047352) Trisomy 18 risk [Likelihood] in Fetus
55
647
0.75
1.37
1.2
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
31
180
1.51
1.37
1.9
1.6
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
17
84
1.78
1.37
1.4
1.4
mmol/l
23.6
22.7
—
10
53
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
2112
19380
0.95
1.37
13.1
7.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
45
282
1.40
1.36
1.1
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
176
1311
1.18
1.36
1.6
1.8
titre
1568.0
3212.3
—
5
52
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
174
1796
0.85
1.35
1.2
1.2
u/ml
3.4
3.8
0.14
41
630
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
64
735
0.76
1.35
1.1
1.1
iu/ml
13.8
9.6
—
7
151
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
147
1539
0.84
1.35
1.7
1.5
%
24.7
28.3
0.65
90
955
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
93
1019
0.80
1.35
1.1
1.3
titre
67.5
61.9
—
8
80
(3005033) Fetal Nuchal fold Thickness US
55
644
0.75
1.34
1.2
1.4
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
19
98
1.70
1.34
1.3
1.1
u/l
13.9
11.3
0.21
19
98
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
26
146
1.56
1.33
1.0
1.2
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
14
66
1.86
1.31
1.4
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
33
197
1.47
1.30
1.0
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
225
1717
1.15
1.30
1.7
1.3
pmol/l
273.8
271.1
0.04
169
1290
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
141
1473
0.84
1.28
1.1
1.1
iu/ml
1.6
1.5
—
6
42
(3011335) Digoxin [Mass/volume] in Serum or Plasma
25
141
1.56
1.27
2.7
2.3
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
31
184
1.48
1.26
1.5
1.7
mmol/l
2.7
2.7
0.05
25
166
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
8
138
0.51
1.25
1.3
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
60
686
0.77
1.25
1.2
1.2
nmol/l
128.6
138.9
0.75
60
686
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
37
228
1.43
1.25
1.1
1.2
%
74.4
74.4
0.00
11
77
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
96
681
1.24
1.25
1.1
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
110
792
1.22
1.24
1.5
1.7
umol/l
20.0
8.9
0.85
82
573
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
55
1.92
1.22
1.7
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
22
122
1.58
1.21
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
77
848
0.80
1.20
1.6
1.6
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
30
0.00
1.17
0.0
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
154
1581
0.85
1.16
1.5
1.4
e6/l
93636.3
140458.8
0.51
108
1082
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
24
314
0.67
1.15
1.2
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
115
841
1.20
1.14
1.3
1.4
nmol/l
1.1
1.3
0.79
92
642
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
182
1388
1.15
1.10
1.1
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
44
287
1.35
1.10
1.4
1.3
mu/l
72.8
62.5
0.16
31
204
(4027681)
86
616
1.23
1.06
1.3
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
29
177
1.44
1.06
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
3652
31210
1.03
1.06
4.7
4.2
kg/l
1.0
1.0
0.31
625
4696
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
97
705
1.21
1.04
4.4
4.8
u/ml
43.0
5944.5
0.55
11
116
(3013945) Hepatitis B virus e Ab [Presence] in Serum
12
59
1.79
1.02
1.9
1.5
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
7
30
2.05
1.02
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
59
653
0.79
1.00
1.3
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
9
139
0.57
0.99
1.0
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
25
0.00
0.98
0.0
8.8
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
26
0.00
0.98
0.0
5.7
—
0.3
—
0
26
(3002621) Streptococcal DNAse B [Units/volume] in Serum
20
115
1.53
0.98
1.2
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
186
0.61
0.96
1.2
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
31
196
1.39
0.96
1.0
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
13
67
1.70
0.96
4.5
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
109
810
1.18
0.95
1.1
1.1
mg/l
339.6
283.3
1.16
93
717
(3036525) Urea [Moles/time] in 24 hour Urine
15
81
1.63
0.94
3.5
2.7
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
16
88
1.60
0.94
1.3
1.3
%
3.7
1.6
0.42
11
51
(3020191) Ethanol [Moles/volume] in Serum or Plasma
106
1096
0.85
0.93
1.3
1.4
promille
1.0
1.3
1.95
78
829
(3030313) Adrenal Ab [Titer] in Serum
13
68
1.68
0.91
1.1
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
45
507
0.78
0.91
1.0
1.1
%
96.9
98.2
0.09
34
396
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
113
1155
0.86
0.87
1.1
1.2
titre
211.3
111.7
—
8
36
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
17
97
1.54
0.87
1.1
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
1140
9561
1.05
0.87
3.3
3.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
285
2276
1.10
0.86
2.5
1.2
u/l
72.0
25.1
2.71
250
1952
(3007916) DNA double strand Ab [Titer] in Serum
14
190
0.65
0.85
1.1
1.3
—
184.8
—
0
13
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
115
870
1.16
0.84
1.3
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
74
780
0.83
0.83
1.6
1.5
%
2.8
4.4
0.95
24
167
(3032868) Hemoglobin electrophoresis panel in Blood
6
101
0.52
0.83
1.5
1.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
114
1157
0.86
0.82
1.1
1.2
titre
150.6
194.2
0.24
17
211
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
111
1128
0.86
0.81
1.2
1.2
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
6
28
1.88
0.81
1.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
54
382
1.24
0.80
1.8
1.6
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
23
0.00
0.79
0.0
1.4
—
2.3
—
0
23
(3017958) Strawberry IgE Ab [Units/volume] in Serum
0
24
0.00
0.78
0.0
1.0
—
0.0
—
0
12
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
604
4998
1.06
0.77
1.5
1.6
titre
270.8
287.9
0.05
19
246
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
115
877
1.15
0.77
1.3
1.2
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
36
406
0.78
0.76
7.1
5.6
%
67.0
70.5
0.28
29
338
(3028679) Herpes simplex virus Ab [Presence] in Serum
73
538
1.19
0.75
1.1
1.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
9
48
1.65
0.73
1.1
1.0
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
20
244
0.72
0.73
1.3
1.5
%
76.7
71.7
1.74
20
232
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
6
96
0.55
0.72
1.0
1.0
—
—
—
0
0
(4015189)
62
452
1.21
0.72
1.9
2.4
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
20
243
0.72
0.71
1.3
1.5
mu/l
376.6
687.2
1.13
20
231
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
80
821
0.86
0.70
1.0
1.1
nmol/l
1.8
5.9
1.29
15
166
(3028714) Urate [Moles/time] in 24 hour Urine
5
23
1.91
0.70
1.2
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
481
3970
1.07
0.69
2.2
2.3
ug/min
109.7
111.4
0.03
257
2306
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
25
291
0.75
0.69
1.8
2.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
47
504
0.82
0.67
1.1
1.1
miu/ml
1443.1
1589.0
0.36
47
504
(3051101) Glucose [Moles/volume] in Cord blood
31
348
0.78
0.66
5.2
6.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
28
188
1.31
0.65
1.3
1.2
—
—
—
0
0
(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum
5
25
1.76
0.65
1.0
1.0
—
32.5
—
0
5
(3029396) Erythrocyte agglutination [Presence] in Blood
16
98
1.43
0.63
1.6
2.6
—
—
—
0
0
(3017400) Magnesium [Moles/volume] in Urine
5
26
1.69
0.62
1.0
1.0
mmol/l
2.8
2.2
—
5
18
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
68
698
0.85
0.62
1.1
1.2
ratio
1.1
1.1
0.40
26
240
(3013293) Extractable nuclear Ab [Presence] in Serum
32
221
1.27
0.62
1.5
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
43
308
1.23
0.61
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
36
392
0.81
0.61
1.1
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
17
0.00
0.61
0.0
2.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
18
0.00
0.61
0.0
1.3
—
—
—
0
0
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
18
0.00
0.61
0.0
1.7
—
28.4
—
0
13
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
18
0.00
0.61
0.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
49
516
0.83
0.60
1.6
1.3
%
62.4
57.3
0.46
44
444
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
110
856
1.13
0.60
1.2
1.1
mg/l
51.8
42.2
0.93
90
721
(3005011) Chlamydia sp Ab [Titer] in Serum
14
174
0.71
0.59
1.6
1.7
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
27
303
0.78
0.59
1.2
1.4
mmol/l
8.2
8.5
0.14
13
180
(3017166) Chili Pepper IgE Ab [Units/volume] in Serum
0
20
0.00
0.59
0.0
1.0
—
0.3
—
0
15
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
56
581
0.85
0.59
1.1
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
161
1283
1.10
0.58
1.2
1.1
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
18
115
1.37
0.58
1.3
1.4
%
20.7
45.3
1.74
12
71
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
140
1108
1.11
0.58
1.1
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
39
418
0.82
0.58
1.2
1.3
%
38.0
37.0
0.06
29
275
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
69
521
1.16
0.58
1.6
2.0
ug/l
59.4
57.7
0.09
69
506
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
48
351
1.20
0.57
2.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
45
327
1.21
0.57
1.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
44
319
1.21
0.57
1.1
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
67
682
0.86
0.56
1.1
1.2
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
5
77
0.57
0.56
1.0
1.0
u/ml
0.0
0.2
—
5
53
(3025886) Oxalate [Mass/time] in 24 hour Urine
6
33
1.60
0.55
1.2
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
39
281
1.22
0.54
1.1
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
21
140
1.32
0.53
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
34
365
0.82
0.53
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
48
498
0.85
0.52
1.3
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
11
65
1.49
0.52
2.6
1.0
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
36
259
1.22
0.52
1.2
1.3
titre
136.4
179.8
—
7
25
(3027456) Digoxin [Moles/volume] in Serum or Plasma
392
3256
1.06
0.51
2.8
3.1
nmol/l
0.9
0.8
0.88
286
2533
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
43
316
1.20
0.51
1.2
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
188
0.75
0.50
7.1
5.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
643
5886
0.96
0.50
1.4
1.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
78
604
1.13
0.49
1.1
1.1
u/l
1.1
1.0
0.44
43
282
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
7
96
0.64
0.48
1.0
1.1
—
14.9
—
0
25
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
50
375
1.17
0.48
1.4
1.3
umol/l
2.7
3.3
0.96
42
345
(3038071) Oxygen [Partial pressure] in Mixed venous blood
35
370
0.83
0.48
5.1
7.7
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
5
73
0.60
0.46
1.0
1.0
u/ml
—
0.3
—
0
27
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
5
73
0.60
0.46
1.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
8
105
0.67
0.46
1.1
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
37
272
1.19
0.45
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
181
1712
0.93
0.44
1.1
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
15
98
1.34
0.44
1.1
1.0
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
13
0.00
0.41
0.0
1.2
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
13
0.00
0.41
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
72
563
1.12
0.41
1.1
1.1
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
16
0.00
0.40
0.0
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
19
132
1.26
0.39
1.1
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
74
583
1.12
0.38
1.4
1.8
umol/l
77.2
111.8
1.35
39
297
(3032743) Legionella sp IgG Ab [Presence] in Serum
15
101
1.30
0.38
1.0
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
187
1751
0.94
0.37
1.1
1.1
au/ml
11.3
14.6
0.28
11
76
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
37
378
0.86
0.37
1.3
1.5
ug/l
0.4
0.4
0.78
26
233
(3020650) Glucose [Presence] in Urine
30
312
0.84
0.37
1.1
1.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
98
0.72
0.37
1.4
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
18
125
1.26
0.37
1.0
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
57
564
0.89
0.37
1.2
1.1
u/ml
2.8
8.9
—
5
45
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
258
2148
1.06
0.36
1.1
1.1
iu/ml
51.6
5677.6
0.56
58
430
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
5
67
0.66
0.36
1.0
1.0
u/ml
0.0
0.7
—
5
39
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
47
362
1.14
0.35
1.1
1.8
%
246.0
183.0
2.25
47
338
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
267
2228
1.05
0.35
1.1
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
9
111
0.71
0.35
1.1
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
15
103
1.28
0.34
1.0
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
27
280
0.85
0.33
1.0
1.0
u/ml
0.7
1.2
—
9
140
(3029075) Extractable nuclear Ab panel - Serum
37
373
0.87
0.33
1.1
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
13
88
1.30
0.32
1.0
1.1
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
15
104
1.27
0.32
1.4
1.4
%
18.1
11.1
—
10
67
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
19
136
1.23
0.32
1.0
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
18
128
1.24
0.32
1.6
2.2
mmol/l
0.7
1.2
—
9
83
(3005082) Progesterone [Moles/volume] in Serum or Plasma
15
164
0.80
0.31
1.4
1.3
nmol/l
25.2
29.8
0.36
15
137
(40768446) Kidney Pathology biopsy report
53
519
0.90
0.31
1.4
1.6
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
86
0.71
0.31
1.1
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
89
720
1.09
0.30
1.3
1.3
—
—
—
0
0
(4212803)
16
113
1.24
0.30
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
937
8041
1.02
0.30
2.5
2.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
359
3034
1.04
0.30
1.6
1.6
nmol/l
0.8
0.8
0.46
302
2499
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
453
4110
0.97
0.28
1.3
1.6
g/l
1.2
1.2
0.20
430
3887
(3006462) Nitrate [Presence] in Urine
86
699
1.08
0.27
3.6
3.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
20
208
0.84
0.27
9.7
10.7
mmol/l
5.0
5.4
0.45
20
208
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
30
300
0.88
0.25
4.7
7.5
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
43
339
1.11
0.25
1.1
1.2
pmol/l
241.3
296.9
0.43
30
235
(3034092) Cytoplasmic Ig cells/100 cells in Blood
23
173
1.17
0.25
14.0
9.6
—
—
—
0
0
(3025315) Body weight
11
121
0.80
0.25
5.2
4.8
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
13
140
0.82
0.25
1.4
1.6
umol/l
43.6
45.5
0.08
13
140
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
12
84
1.25
0.24
1.9
2.6
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
22
166
1.16
0.23
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
25
191
1.15
0.23
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
62
502
1.08
0.23
1.2
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
110
1022
0.94
0.22
1.5
2.0
mmol/l
7.6
7.0
0.99
84
695
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
48
385
1.10
0.22
1.3
1.2
—
—
—
0
0
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
9
0.00
0.21
0.0
1.6
—
—
—
0
0
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
116
965
1.06
0.21
2.2
2.5
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
12
0.00
0.20
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
12
0.00
0.20
0.0
1.0
—
138.9
—
0
12
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
12
0.00
0.20
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
27
210
1.13
0.20
1.1
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
30
294
0.90
0.20
1.4
1.2
umol/l
16.4
16.5
0.03
25
270
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
447
4023
0.98
0.20
1.3
1.6
g/l
0.2
0.2
1.39
424
3804
(3002523) Influenza virus A Ag [Presence] in Specimen
151
1385
0.96
0.19
1.2
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
92
763
1.06
0.19
2.1
2.2
ug/min
109.5
133.2
0.11
20
183
(3006270) Folate [Moles/volume] in Blood
152
1279
1.04
0.19
1.1
1.2
nmol/l
320.4
346.4
0.83
116
1042
(3016330) Potassium [Moles/time] in 24 hour Urine
20
200
0.88
0.18
1.3
1.2
—
90.3
—
0
7
(3047007) Chlamydophila sp Ab [Presence] in Serum
182
1658
0.96
0.18
1.2
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
170
1438
1.04
0.17
3.0
3.0
mg/l
51.6
43.6
0.18
130
1027
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
51
416
1.08
0.17
1.2
1.2
g/l
0.3
0.3
1.35
46
339
(4211845)
91
759
1.05
0.17
3.5
3.1
—
—
—
0
0
(4133840)
43
349
1.08
0.16
1.4
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
234
1994
1.03
0.16
1.3
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
152
1385
0.96
0.16
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
93
778
1.05
0.16
1.1
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
67
555
1.06
0.16
1.7
2.3
umol/l
57.0
56.0
0.08
54
439
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
28
223
1.10
0.15
1.3
1.3
%
60.7
48.3
0.68
15
101
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
6
70
0.75
0.15
5.7
3.4
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
9
68
1.16
0.15
1.4
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
9
70
1.13
0.15
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
452
4047
0.98
0.15
1.5
1.6
iu/ml
0.4
6.5
0.94
127
898
(43055442) Apixaban [Mass/volume] in Serum or Plasma
22
215
0.90
0.15
1.1
1.6
ug/l
124.9
117.2
0.12
17
178
(3027570) Oxalate [Moles/time] in 24 hour Urine
7
77
0.80
0.14
2.9
1.3
umol/24h
621.4
312.4
—
7
77
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
45
423
0.93
0.14
5.2
7.8
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
15
149
0.88
0.13
1.0
1.0
ug/l
104.8
80.3
—
10
111
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
15
116
1.14
0.13
1.1
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
107
905
1.04
0.12
2.0
2.1
nmol/l
17.7
16.7
0.52
100
839
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
21
167
1.10
0.12
1.4
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
6458
56897
1.00
0.12
2.2
2.2
nmol/l
75.9
78.5
10.59
5918
49998
(3033923) Metanephrine [Moles/time] in 24 hour Urine
33
311
0.93
0.12
1.1
1.1
umol/24h
0.6
0.7
0.49
16
138
(3036670) Protein [Mass/volume] in Synovial fluid
57
526
0.95
0.11
1.4
1.3
g/l
37.7
40.0
0.64
33
276
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
17
134
1.11
0.11
1.2
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
17
134
1.11
0.11
1.9
1.6
—
—
—
0
0
(3013762) Body weight Measured
5
39
1.13
0.10
1.0
1.2
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
38
315
1.06
0.09
1.1
1.3
mg/l
1.3
34.8
0.98
29
241
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
6
47
1.12
0.09
1.0
1.3
%
1.3
1.3
—
6
47
(3023511) Choriogonadotropin [Units/volume] in Urine
97
827
1.03
0.08
1.7
1.3
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
5
53
0.83
0.08
1.2
1.2
u/l
2778.0
267.3
—
5
43
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
6
62
0.85
0.07
1.2
1.0
mmol/l
9.2
8.5
—
6
62
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
75
0.82
0.07
1.0
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
9
76
1.04
0.07
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
373
3310
0.99
0.06
1.3
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
44
401
0.96
0.06
1.1
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
58
495
1.03
0.05
30.8
35.9
ug/l
7.2
7.3
0.27
46
454
(3044927) Protein electrophoresis panel - Urine
187
1621
1.01
0.05
1.1
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
11
88
1.10
0.05
1.0
1.3
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
14
132
0.93
0.04
1.1
1.1
u/ml
0.0
0.6
—
8
82
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
52
469
0.97
0.04
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
92
794
1.02
0.04
11.0
10.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
3802
33335
1.00
0.03
4.1
3.8
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
52
446
1.02
0.03
1.2
1.2
g/l
0.8
0.4
—
7
26
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
49
420
1.02
0.03
1.1
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
10
95
0.92
0.03
1.0
1.7
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
10
81
1.08
0.02
6.1
8.6
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
12
99
1.06
0.02
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
120
1045
1.01
0.01
1.1
1.2
mmol/l
11.7
11.9
0.12
49
301
(3034426) Prothrombin time (PT)
44
392
0.99
0.00
1.2
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
273
2391
1.00
0.00
1.8
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
357
3129
1.00
0.00
1.1
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
16
140
1.00
0.00
1.1
1.1
umol/24h
1.7
1.7
0.07
16
140
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
22
190
1.02
0.00
1.0
1.4
—
50.5
—
0
9
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
18
161
0.98
0.00
2.2
2.0
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
112
979
1.00
0.00
1.1
1.1
mg/l
303.8
286.9
1.69
98
879
(3000285) Sodium [Moles/volume] in Blood
26
229
1.00
0.00
1.1
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
17
153
0.98
0.00
2.2
2.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
60
529
1.00
0.00
1.6
1.5
ug/l
8.3
9.6
0.35
54
456
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
13
119
0.96
0.00
1.1
1.3
%
32.6
22.6
—
5
32
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
68
599
1.00
0.00
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
39
347
0.99
0.00
1.5
1.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
14
126
0.98
0.00
1.3
1.6
—
—
—
0
0
(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3014178) Parietal cell Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
170.3
—
0
6
(3033463) Neutrophils [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
5
45
0.98
0.00
1.0
1.4
mmol/l
5.6
16.3
—
5
32
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36031836) Tocilizumab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
19.1
—
0
6
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
5.4
—
0
6
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015057) Respiratory syncytial virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009220) Epithelial cells.squamous [#/volume] in Urine sediment
0
6
0.00
0.00
0.0
1.2
—
1.5
—
0
6
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_UNCERTAIN_SECONDARY_EXALLC – Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).